Document:

Exhibit 10.1.6 

  CONFIDENTIAL

 CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL

PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE

BEEN SEPARATELY FILED WITH THE COMMISSION

CONSENT AND FIFTH AMENDMENT

TO

LOAN AND SECURITY AGREEMENT

       THIS CONSENT
AND FIFTH  AMENDMENT TO LOAN AND  SECURITY  AGREEMENT  (this  “Fifth
Amendment”)  dated as of January  19,  2010 is by and among  EXAMWORKS,
INC.,  a Delaware  corporation  (“Parent”),  SOUTHWEST  MEDICAL
EXAMINATION SERVICES, INC., a Texas corporation, THE RICWEL CORPORATION, an Ohio
corporation,  CFO MEDICAL SERVICES, LLC, a New Jersey limited liability company,
DIAGNOSTIC  IMAGING  INSTITUTE,  INC.,  a  Texas  corporation,  RICWEL  OF  WEST
VIRGINIA,  LLC, a West  Virginia  limited  liability  company,  PACIFIC  BILLING
SERVICES,  INC.,  a Texas  corporation,  SET-ASIDE  SOLUTIONS,  LLC,  a Delaware
limited  liability  company,  MARQUIS MEDICAL  ADMINISTRATORS,  INC., a New York
corporation,  IME SOFTWARE SOLUTIONS, LLC, a Michigan limited liability company,
FLORIDA  MEDICAL  SPECIALISTS,   INC.,  a  New  Jersey  corporation,   EXAMWORKS
EVALUATIONS  OF NEW YORK,  LLC, a New York limited  liability  company,  and the
subsidiaries  of Parent  that may from  time to time  hereafter  become  parties
hereto  and  the  Loan   Agreement   (the   foregoing,   together  with  Parent,
individually,        “Borrower”        and        collectively,
“Borrowers”),  FIFTH THIRD BANK, an Ohio banking corporation in
its capacity as administrative agent for Lenders identified below (together with
its successors and assigns, “Administrative  Agent”), and FIFTH
THIRD BANK, in its individual capacity, and BANK OF AMERICA, N.A. (collectively,
“Lenders”).

RECITALS:

      WHEREAS, Borrowers, Administrative Agent and Lenders are parties to that certain Loan and Security Agreement dated as of December 18, 2009, as amended pursuant to certain consents and amendments among the parties hereto (as the same may be further amended, supplemented or modified from time to time, collectively with all such consents and amendments, the “Loan Agreement”); all capitalized terms used but not defined herein shall have the meanings ascribed thereto in the Loan Agreement; and

      WHEREAS, Borrower requests Administrative Agent to consent to certain matters as provided herein, and Borrower, Administrative Agent and Lenders desire to amend certain provisions of the Loan Agreement, in each case in accordance with, and subject to, the terms and conditions set forth herein.

      NOW, THEREFORE, for and in consideration of the mutual covenants and agreements contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto (intending to be legally bound) hereby agree as follows:

      1. Consent; Joinder. (a) Subject to the terms and conditions set forth in this Fifth Amendment, and notwithstanding anything in the Financing Agreements to the contrary, from and after the Fifth Amendment Effective Date, Administrative Agent and Lenders consent to the formation by Parent of a newly organized, wholly-owned subsidiary named ExamWorks Evaluations of New York, LLC, a New York limited liability company (“ExamWorks Evaluations”).

 CONFIDENTIAL

     (b)  ExamWorks
Evaluations  hereby  absolutely and  unconditionally  (i) joins as and becomes a
party to the Loan Agreement as a Borrower  thereunder,  (ii) assumes, as a joint
and  several  obligor  thereunder,  all  of  the  obligations,  liabilities  and
indemnities  of  Borrower  under  the Loan  Agreement  and all  other  Financing
Agreements (including, without limitation, the Liabilities), (iii) covenants and
agrees  to be  bound  by  and  adhere  to all  of  the  terms,  representations,
warranties,  covenants,  waivers,  releases,  agreements  and  conditions  of or
respecting  Borrower with respect to the Loan Agreement and the other  Financing
Agreements,  and (iv) collaterally assigns and transfers to Administrative Agent
(for the  ratable  benefit of the  Lenders and the  Administrative  Agent),  and
hereby grants to Administrative  Agent (for the ratable benefit of the Lenders),
a continuing security interest in all of ExamWorks  Evaluations’  now owned
and hereafter  acquired or arising  assets and other  Collateral,  as collateral
security for the prompt and complete  payment and performance  when due (whether
at the stated maturity, by acceleration or otherwise) of all of the Liabilities.
Any reference to the term “Borrower”  or “Borrowers”  in the
Loan  Agreement  shall  mean and  include  ExamWorks  Evaluations  and all other
parties identified as a Borrower in the Preamble to this Fifth Amendment.

     2. Amendments to Loan Agreement. Subject to the terms and conditions contained herein, the parties hereto hereby amend the Loan Agreement as follows:

           a. The definition of “Borrower” as set forth in the Preamble to the Loan Agreement is hereby amended by deleting the reference to “Crossland Medical Review Services, Inc., a New York corporation (“Crossland”)” therein and adding a reference to “ExamWorks Evaluations of New York, LLC, a New York limited liability company” therein.

           b. Section 1.1 of the Loan Agreement is hereby amended as follows:

        i. the definition of “Parent Pledge Agreement” therein shall include any amendment or modification thereof dated as of the Fifth Amendment Effective Date made in connection with this Fifth Amendment.

        ii. the definition of “Intellectual Property Security Agreement” therein shall include any amendment or modification thereof dated as of the Fifth Amendment Effective Date made in connection with this Fifth Amendment.

           c. Section 1.1 of the Loan Agreement is hereby further amended by adding the following new defined term in alphabetical order:
  

 “Fifth Amendment Effective Date” means January 19, 2010.

           d. The definition of “Revolving Credit Notes” in Section 2.1(d) of the Loan Agreement is hereby amended to include any amendment or modification thereof dated as of the Fifth Amendment Effective Date made in connection with this Fifth Amendment.

 -2-

 CONFIDENTIAL

           e. The definition of “Term Loan Notes” in Section 2.3(c) of the Loan Agreement is hereby amended to include any amendment or modification thereof dated as of the Fifth Amendment Effective Date made in connection with this Fifth Amendment.

           f. Schedule 4.7 (Borrower Locations) of the Loan Agreement is hereby amended and restated with Schedule 4.7 attached hereto.

           g. Schedule 7.5 (Organizational Numbers) of the Loan Agreement is hereby amended and restated with Schedule 7.5 attached hereto.

           h. Schedule 7.8 (Other Names) of the Loan Agreement is hereby amended and restated with Schedule 7.8 attached hereto.

           i. Schedule 7.16 (Intellectual Property) of the Loan Agreement is hereby amended and restated with Schedule 7.16 attached hereto.

           j. Schedule 9.2 (Certain Unsecured Indebtedness) of the Loan Agreement is hereby amended and restated with Schedule 9.2 attached hereto.

           k. Section 7.1 of the Loan Agreement shall hereafter also reflect that ExamWorks Evaluations is a limited liability company validly existing and in good standing under the laws of the State of New York.

           l. Section 7.7 of the Loan Agreement shall hereafter also reflect that ExamWorks Evaluations’ principal place of business and chief executive office is located at 3280 Peachtree Road, Suite 2625, Atlanta, Georgia 30305, and its State of organization is New York.

           m. Section 7.8 of the Loan Agreement shall hereafter also reflect that Borrower has used the following name: “ExamWorks Evaluations of New York, LLC”.

           n. Section 7.12 of the Loan Agreement shall hereafter also reflect that ExamWorks Evaluations is a wholly-owned subsidiary of Parent and that Crossland is no longer a subsidiary of Parent.

           o. References in Section 8.5 and Section 9.16 of the Loan Agreement to the State of organization of Borrower shall also contain a reference to the State of New York with respect to ExamWorks Evaluations.

      3. No Other Consents or Amendments. Notwithstanding the consent and amendments set forth in Sections 1 and 2 hereof, Ultimate Parent and Borrowers acknowledge and expressly agree that this Fifth Amendment is limited to the extent expressly set forth herein and shall not constitute a modification or further amendment of the Loan Agreement or any other Financing Agreements or a course of dealing at variance with the terms of the Loan Agreement or any other Financing Agreements (other than as expressly set forth in this Fifth Amendment).

 -3-

 CONFIDENTIAL

     4. Representations and Warranties. Ultimate Parent and each of Borrowers hereby represent and warrant to and in favor of the Administrative Agent and Lenders, which representations and warranties shall survive the execution and delivery hereof, as follows:

           a. Each representation and warranty set forth in Section 7 of the Loan Agreement is hereby restated and affirmed as true and correct in all material respects as of the date hereof, except to the extent previously fulfilled in accordance with the terms of the Loan Agreement, as amended hereby;

           b. Ultimate Parent and each of Borrowers has the company power and authority (i) to enter into this Fifth Amendment and (ii) to do all acts and things as are required or contemplated hereunder to be done, observed and performed by it;

            c.  This Fifth
Amendment  has been duly  authorized,  validly  executed and delivered by one or
more Duly Authorized Officers of Ultimate Parent and each of Borrowers, and each
of this Fifth Amendment and the Loan Agreement  constitutes the legal, valid and
binding  obligations  of  Borrowers  (and each of this Fifth  Amendment  and the
Financing  Agreements to which Ultimate Parent is a party constitutes the legal,
valid and binding obligations of Ultimate Parent), enforceable against Borrowers
and Ultimate Parent,  respectively,  in accordance with their respective  terms,
subject, as to enforcement of remedies, to the following qualifications:  (i) an
order of specific performance and an injunction are discretionary  remedies and,
in  particular,  may not be available  where damages are  considered an adequate
remedy at law and (ii)  enforcement  may be limited by  bankruptcy,  insolvency,
liquidation,  reorganization,  reconstruction  and other similar laws  affecting
enforcement of creditors’ rights generally (insofar as any such law relates
to the  bankruptcy,  insolvency  or  similar  event of  Ultimate  Parent or such
Borrower);

           d. The execution and delivery of this Fifth Amendment and performance by the Ultimate Parent and each of Borrowers under this Fifth Amendment, the Loan Agreement and each of the other Financing Agreements to which each is a party do not and will not require the consent or approval of any regulatory authority or governmental authority or agency having jurisdiction over Ultimate Parent or any Borrower which has not already been obtained, nor be in contravention of or in conflict with the organizational documents of Ultimate Parent and each of Borrowers, or any provision of any statute, judgment, order, indenture, instrument, agreement, or undertaking, to which Ultimate Parent or any Borrower is party or by which Ultimate Parent’s or any Borrower’s assets or properties are bound;

           e. No Default or Event of Default exists both before and after giving effect to this Fifth Amendment, and no event has occurred that has had or could reasonably be expected to have a Material Adverse Effect; and

           f. The legal name of ExamWorks Evaluations is “Exam Works Evaluations of New York, LLC.” ExamWorks Evaluations is a New York limited liability company, and the Secretary of State of the State of New York does not assign organizational number to limited liability companies.

 -4-

 CONFIDENTIAL

     5. Conditions Precedent to Effectiveness of this Fifth Amendment. The consent contained in Section 1(a) of this Fifth Amendment shall become effective on the date hereof subject to:

           a. all of the representations and warranties of the Ultimate Parent and Borrowers under Section 4 hereof, which are made as of the date hereof, being true and correct in all material respects;

           b. receipt by Administrative Agent of duly executed signature pages to this Fifth Amendment from the Ultimate Parent, each of Borrowers and Lenders;

           c. receipt by Administrative Agent of such duly executed and delivered resolutions (including with respect to the underlying Loan Agreement as amended with respect to ExamWorks Evaluations), certified Organization Documents, good standing certificates, secretary’s certificate, Landlord Waivers (if applicable), and such other related certificates and documents (if any), reasonably required by Administrative Agent in connection with this Fifth Amendment;

           d. receipt by Administrative Agent of true, correct and complete duly executed copies of (i) a Reaffirmation and Amendment of Pledge Agreement by Parent, (ii) a First Modification to Revolving Credit Note by Borrowers with respect to the Revolving Credit Note of each Lender, respectively, and (iii) a First Modification to Term Loan Note by Borrowers with respect to the Term Loan Note of each Lender, respectively;

           e. Certificates of Insurance in form and substance satisfactory to Administrative Agent, from Borrower’s insurance carriers reflecting the certificates to be issued and delivered to Lender pursuant to Section 5.2(b)(i) of the Loan Agreement reflecting the addition of ExamWorks Evaluations as a co-borrower (together with a Loss Payable Endorsement signed by the applicable insurance agent);

           f. UCC Financing Statement, as requested by Administrative Agent, naming ExamWorks Evaluations as debtor and Administrative Agent as secured party with respect to ExamWorks Evaluations’ Collateral, shall have been filed with the Delaware Secretary of State;

           g. UCC Financing Statement (or amendment thereto), as requested by Administrative Agent, naming Parent as debtor and Administrative Agent as secured party with respect to the equity of ExamWorks Evaluations owned by Parent, shall have been filed with the Delaware Secretary of State;

           h. receipt by Administrative Agent of the amount of the reasonable fees and out-of-pocket costs and expenses of counsel to Administrative Agent in connection with this Fifth Amendment pursuant to Section 9 hereof and otherwise due and owing pursuant to the Loan Agreement; and

 -5-

 CONFIDENTIAL

          i. receipt by Administrative Agent of such other assurances, certificates, schedules, exhibits, documents, consents or opinions as Administrative Agent or the Required Lenders reasonably may require.

      6. [Intentionally Omitted].

      7. Reaffirmation; References to Loan Agreement.

           a. Each Borrower and Ultimate Parent acknowledges and agrees that all of their respective obligations and Liabilities under the Loan Agreement, as amended hereby, shall be valid and enforceable and shall not be impaired or limited by the execution or effectiveness of this Fifth Amendment.

           b. Upon the effectiveness of this Fifth Amendment, each reference in the Loan Agreement to “this Agreement,” “hereunder,” “hereof,” “herein” or words of like import shall mean and be a reference to the Loan Agreement, as amended by this Fifth Amendment.

           c. The failure by Administrative Agent, at any time or times hereafter, to require strict performance by any Borrower of any provision or term of the Loan Agreement, this Fifth Amendment or any of the Financing Agreements shall not waive, affect or diminish any right of Administrative Agent hereafter to demand strict compliance and performance herewith or therewith. Any suspension or waiver by Administrative Agent of a breach of this Fifth Amendment or any Event of Default under the Loan Agreement shall not, except as expressly set forth in a writing signed by Administrative Agent (and, if applicable, Required Lenders), suspend, waive or affect any other breach of this Fifth Amendment or any Event of Default under the Loan Agreement, whether the same is prior or subsequent thereto and whether of the same or of a different kind or character. None of the undertakings, agreements, warranties, covenants and
representations of any Borrower
contained in this Fifth Amendment, shall be deemed to have been suspended or waived by Administrative Agent unless such suspension or waiver is (i) in writing and signed by Administrative Agent and (ii) delivered to Parent. In no event shall Administrative Agent's execution and delivery of this Fifth Amendment establish a course of dealing among Administrative Agent, Ultimate Parent, Parent or any other Borrower or any other obligor, or in any other way obligate Administrative Agent to hereafter provide any amendments or, if at any time applicable, waivers with respect to the Loan Agreement. The terms and provisions of this Fifth Amendment shall be limited precisely as written and shall not be deemed (x) to be a consent to any amendment or modification of any other term or condition of the Loan Agreement or of any of the Financing Agreements (except as expressly provided herein); or (y) to prejudice any right or remedy which Administrative Agent may now have under or in connection with the Loan
Agreement or any of the Financing Agreements.

 -6-

 CONFIDENTIAL

           d. Except as expressly provided herein, the Loan Agreement and all Financing Agreements shall remain unaltered and in full force and effect and are hereby ratified and confirmed in all respects.

      8. Release.

           a. In consideration of, among other things, the consents and amendments provided for herein, and for other good and valuable consideration, as of the date hereof, the Ultimate Parent, Parent and each other Borrower (on behalf of themselves and their respective Subsidiaries and Affiliates), their successors-in-title, legal representatives and assignees and, to the extent the same is claimed by right of, through or under the above, for their past, present and future employees, members, managers, partners, agents, representatives, officers, directors, shareholders and trustees (all collectively, with Ultimate Parent, Parent and each other Borrower, the “Releasing Parties”), do hereby unconditionally and forever remise, satisfy, acquit, release and discharge the Administrative Agent and Lenders and any of their respective successors-in-title, legal representatives and assignees, past, present and future

officers, directors,
shareholders, trustees, agents, employees, consultants, experts, advisors, attorneys and other professionals and all other persons and entities to whom any of the Administrative Agent and Lenders would be liable if such persons or entities were found in any way to be liable to any of the Releasing Parties (collectively hereinafter the “Lender Parties”), from any and all manner of action and actions, cause and causes of action, claims, cross-claims, charges, demands, counterclaims, suits, debts, dues, sums of money, accounts, reckonings, bonds, bills, specialties, covenants, contracts, controversies, damages, judgments, liabilities, damages, expenses, executions, liens, claims of liens, claims of costs, penalties, attorneys' fees, or any other compensation, recovery or relief on account of any liability, obligation, demand or cause of action of whatever nature, whether in law, equity or otherwise (including, without limitation, those arising under 11 U.S.C. §§ 541-550 and
interest or other carrying costs, penalties, legal, accounting and other professional fees and expenses, and incidental, consequential and punitive damages payable to third parties), whether known or unknown, fixed or contingent, joint and/or several, secured or unsecured, due or not due, primary or secondary, liquidated or unliquidated, contractual or tortious, direct, indirect, or derivative, asserted or unasserted, foreseen or unforeseen, suspected or unsuspected, now existing, heretofore existing or which may have heretofore accrued against any or all of the Lender Parties, whether held in a personal or representative capacity, and which are based on any act, fact, event or omission or other matter, cause or thing occurring at or from any time prior to and including the date hereof in any way, directly or indirectly arising out of, connected with or relating to this Fifth Amendment, the Loan Agreement or any other Financing Agreement and the transactions contemplated hereby and thereby, and all
other agreements, certificates, instruments and other documents and statements (whether written or oral) related to any of the foregoing. Borrower, Parent and Ultimate Parent acknowledges that Administrative Agent is specifically relying upon the representations, warranties and agreements contained herein and that such representations, warranties and agreements constitute a material inducement to Administrative Agent in entering into this Fifth Amendment.

 -7-

 CONFIDENTIAL

           b. Each of the Ultimate Parent, Parent and each other Borrower hereby knowingly, voluntarily, intentionally and expressly waives and relinquishes any and all rights and benefits that it may have as against the Lender Parties under any law, rule or regulation of any jurisdiction that would have the effect of limiting the extent to which a general release extends to claims which a Lender Party or Releasing Party does not know or suspect to exist as of the date hereof. Each of the Ultimate Parent, Parent and each other Borrower hereby acknowledges that the waiver set forth in the prior sentence was separately bargained for and that such waiver is an essential term and condition of this Fifth Amendment (and without which the consent in Section 1(a) hereof would not have been given by Administrative Agent and Lenders).

      9. Costs, Expenses and Taxes. Without limiting the obligation of Borrower to reimburse Administrative Agent for all costs, fees, disbursements and expenses incurred by Administrative Agent as specified in the Loan Agreement, as amended by this Fifth Amendment, Borrower agrees to pay on demand all costs, fees, disbursements and expenses of Administrative Agent in connection with the preparation, negotiation, revision, execution and delivery of this Fifth Amendment and the other agreements, instruments and documents contemplated hereby, including, without limitation, reasonable attorneys' fees and out-of-pocket expenses.

      10. Counterparts. This Fifth Amendment may be executed in multiple counterparts, each of which shall be deemed to be an original and all of which when taken together shall constitute one and the same agreement.

      11. Governing Law. This Fifth Amendment shall be deemed to be made pursuant to the laws of the State of Illinois and shall be construed, interpreted, governed performed and enforced in accordance therewith, without regard to conflict of law principles.

      12. Financing Agreement. This Fifth Amendment shall constitute a Financing Agreement.

      13. Severability; Faxes. Any provision of this Fifth Amendment which is prohibited or unenforceable for any reason shall be ineffective solely to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof in that jurisdiction or affecting the validity or enforceability of such provision in any other jurisdiction. A signature hereto sent or delivered by facsimile or other electronic transmission shall be as legally binding and enforceable as a signed original for all purposes.

      14. Successors and Assigns. This Fifth Amendment shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns; provided, however, neither Ultimate Parent, Parent nor any Borrower may assign any of its respective rights or obligations under this Fifth Amendment without the prior written consent of Administrative Agent.

 [Remainder of page intentionally blank; signature pages follow]

 -8-

 CONFIDENTIAL

      IN WITNESS WHEREOF, the parties hereto have executed this Fifth Amendment to Loan and Security Agreement as of the day and year first above written.

			
	      	 EXAMWORKS, INC.
	  
	 	 By:	       /s/ J. Miguel Fernandez
      de Castro
      

    
	 	 Name: J. Miguel Fernandez de Castro
	 	 Its: Senior Vice President and Chief Financial
	 	 Officer
	 	  
	 	 SOUTHWEST MEDICAL EXAMINATION
	 	    SERVICES,
      INC.
	 	 THE RICWEL CORPORATION
	 	 DIAGNOSTIC IMAGING INSTITUTE, INC.
	 	 PACIFIC BILLING SERVICES, INC.
	 	 MARQUIS MEDICAL ADMINISTRATORS, INC.
	 	 FLORIDA MEDICAL SPECIALISTS, INC.
	 	  
	 	 By:	       /s/ J. Miguel Fernandez
      de Castro
      

    
	 	 Name: J. Miguel Fernandez de Castro
	 	 Its: Senior Vice President and Chief Financial
	 	 Officer
	 	  
	 	 CFO MEDICAL SERVICES, LLC
	 	 RICWEL OF WEST VIRGINIA, LLC
	 	  
	 	 By: ExamWorks, Inc., its sole member and manager
	 	  
	 	 By:	       /s/ J. Miguel Fernandez
      de Castro
      

    
	 	 Name: J. Miguel Fernandez de Castro
	 	 Its: Senior Vice President and Chief Financial
	 	 Officer
	 	  
	 	 SET-ASIDE SOLUTIONS, LLC
	 	 IME SOFTWARE SOLUTIONS, LLC
	 	EXAMWORKS EVALUATIONS OF NEW YORK, LLC
	 	  
	 	 By: ExamWorks, Inc., its sole member
	 	  
	 	 By:	       /s/ J. Miguel Fernandez
      de Castro
      

    
	 	 Name: J. Miguel Fernandez de Castro
	 	 Its: Senior Vice President and Chief Financial
	 	 Officer

 EXAMWORKS, INC.

CONSENT AND FIFTH AMENDMENT TO LOAN AND SECURITY AGREEMENT

 CONFIDENTIAL

		
	 Acknowledged and Agreed:
	  
	 EXAMWORKS HOLDINGS, LLLP
	 By: Compass Partners, L.L.C., its General Partner
	  
	 By:     	       /s/ Richard E. Perlman
      

    
	 Name: Richard E. Perlman
	 Its: President

 EXAMWORKS, INC.

CONSENT AND FIFTH AMENDMENT TO LOAN AND SECURITY AGREEMENT

 CONFIDENTIAL

			
	     	 FIFTH THIRD BANK,
	 	 as Administrative Agent and a Lender
	 	  	 
	 	 By:	       /s/
      Philip Renwick
      

    
	 	  	 Philip Renwick
	 	  	 Vice President
	 	  	 
	 	  	 
	 	 BANK OF AMERICA, N.A.,
	 	 as a Lender
	 	  	 
	 	 By:	       /s/
      Shawn Janko
      

    
	 	  	 Shawn Janko
	 	  	 Senior Vice President

 EXAMWORKS, INC.

CONSENT AND FIFTH AMENDMENT TO LOAN AND SECURITY AGREEMENT

 CONFIDENTIAL

Schedule 4.7

Borrower Locations

	 Company Name
    	 Address
    
	 ExamWorks Holdings, LLLP
    	 3280 Peachtree Road

     Suite 2625

     Atlanta, GA 30305
    
	 ExamWorks, Inc.
    	 3280 Peachtree Road

     Suite 2625

     Atlanta, GA 30305
    
	 ExamWorks Evaluations of New York, LLC
    	 3280 Peachtree Road

     Suite 2625

     Atlanta, GA 30305
    
	 CFO Medical Services, LLC
    	 4 Becker Farm Road

     1st Floor

     Roseland, NJ 07068
    
	 Pacific Billing Services, Inc.
    	 12001 N. Central Expressway

     Dallas, TX 75243
    
	 IME Software Solutions, LLC
    	 3280 Peachtree Road

     Suite 2625

     Atlanta, GA 30305
    
	 Southwest Medical Examination Services, Inc.
    	 12001 North Central Expressway

     Suite 800

     Dallas, Texas 75243
    
	 Diagnostic Imaging Institute, Inc.
    	 4141 SW Freeway

     Suite 500

     Houston, TX 77027
    
	 Set-Aside Solutions, LLC
    	 3280 Peachtree Road

     Suite 2625

     Atlanta, GA 30305
    
	 The Ricwel Corporation
    	 525 Metro Place North

     Suite 450

     Dublin, OH 43017
    
	 Ricwel of West Virginia, LLC
    	 803 Quarrier Street

     Suite 220

     Charleston, WV 25301
    
	 Marquis Medical Administrators, Inc.
    	 4 Becker Farm Road

     1st Floor

     Roseland, NJ 07068
    

 CONFIDENTIAL

	 Florida Medical Specialists, Inc.
    	 200 E. Las Olas Blvd

       Suite 1660

     Fort Lauderdale, FL 33301
    
	 Benchmark Medical Consultants (a division of ExamWorks, Inc.)
    	 10423 Old Placeville Road

     Suite 100

     Sacramento, CA 95827
    
	 The Evaluation Group (a division of ExamWorks, Inc.)

    	 20300 West 12 Mile Road

     Suite 103

     Southfield, MI 48076
    

 Abeton/MAS

	 Company Name
    	 Address
    
	
     Arizona
	 Exam Works, Inc.
    	 2400 West Dunlap Avenue

     Phoenix, AZ 85021
    
	
     Oregon
	 Exam Works, Inc.
    	 2501 SW First Avenue

     Suite 400

     Portland, OR 97201
    
	 Exam Works, Inc.
    	 1395 Liberty Street SE

     Salem, OR 97302
    
	 Exam Works, Inc.
    	 975 Colorado Avenue

     Suite 110

     Bend, OR 97702
    
	 Exam Works, Inc.
    	 2350 Oakmont Way

     Suite 103

     Eugene, OR 97401
    
	 Exam Works, Inc.
    	 255 Stewart Avenue

     Medford, OR 97501
    
	 Exam Works, Inc.
    	 1100 Southgate

     Suite 10

     Pendleton, OR 97801
    
	
     Utah
	 Exam Works, Inc.
    	 South Temple Medical Plaza

     508 E South Temple,

     Suite 102

     Salt Lake City, UT 84012
    

 CONFIDENTIAL

	
     Washington
	 Exam Works, Inc.
    	 909 SE Everett Mall Way
      Everett, WA 98208
    
	 Exam Works, Inc.
    	 200 North Mullan Road

     Suite 203

     Spokane Valley, WA 99206
    
	 Exam Works, Inc.
    	 2420 South Union

     Suite 240

     Tacoma, WA 98405
    

 QualMed

	 Company Name
    	 Address
    
	 Exam Works, Inc.
    	 Gateway Park, LLC

     523 Fellowship Road

     Suite 275

     Mount Laurel, NJ 08054
    

 MedNet

	 Company Name
    	 Address
    
	 Exam Works, Inc.
    	 11465 Johns Creek Parkway

     Suite 140

     Duluth, GA 30097
    

 Chalal/Zeide

	 Company Name
    	 Address
    
	 Exam Works, Inc.
    	 7593 Boynton Beach Boulevard

     Boynton Beach, FL 33437
    

 CONFIDENTIAL

Schedule 7.5

Organizational Numbers

	 Company Name
    	 Company Number
    
	 ExamWorks Holdings, LLLP
    	 07036066
    
	 ExamWorks, Inc.
    	 4342019
    
	 ExamWorks Evaluations of New York, LLC
    	 N/A
    
	 CFO Medical Services, LLC
    	 0600315820
    
	 Pacific Billing Services, Inc.
    	 800747365
    
	 IME Software Solutions, LLC
    	 B7966D
    
	 Southwest Medical Examination Services, Inc.
    	 123769800
    
	 Diagnostic Imaging Institute, Inc.
    	 126513100
    
	 Set-Aside Solutions, LLC
    	 4713975
    
	 The Ricwel Corporation
    	 697241
    
	 Ricwel of West Virginia, LLC
    	 76308
    
	 Marquis Medical Administrators, Inc.
    	 N/A
    
	 Florida Medical Specialists, Inc.
    	 0100430388
    

 CONFIDENTIAL

Schedule 7.8

Other Names

	 CMRS
	 CFO
	 TEG
	 DII
	 SWME
	 IME Centric
	 FMS
	 Ricwel of OH
	 Ricwel of WV
	 PBS

 Abeton/MAS

	 MAG
	 Medical Assurance Group

 QualMed

	 QualMed

 MedNet

	 MedNet

 Chalal/Zeide

 None.

 CONFIDENTIAL

Schedule 7.16

Intellectual Property

 CFO Medical Services, LLC

 Registered mark no. 2,770,800 for CFO Medical Services

 ExamWorks, Inc.

 Registered mark no. 2,917,614 for Benchmark Medical Consultants (words only)

 Registered service mark no. S19097 for Crossland Medical Review Services: Our Service Is Your Solution!

 IME Software Solutions, LLC

 Registered copyright no. TXu001043714 for IME*Centric 

The Ricwel Corporation 

Registered mark no. 2,545,331 for EFILE

 Registered mark no. 2,316,927 for Vidmed Resolutions

 Southwest Medical Examination Services, Inc.

 Registered service mark no. 3,041,490 for Southwest Medical Examination Services

 Abeton/MAS

 Abeton, Inc.

 Registered service mark no. 3,509,987 for Abeton

 QualMed

 Registered mark no. 3577691 for QualMed Evaluations

 MedNet

 None.

 Chalal/Zeide

 None.

 CONFIDENTIAL

Schedule 9.2

Certain Unsecured Indebtedness

 1. [CONFIDENTIAL MATERIAL REDACTED AND FILED SEPARATELY WITH THE COMMISSION]Exhibit 10.1.7 

 CONSENT AGREEMENT

TO

LOAN AND SECURITY AGREEMENT

       THIS CONSENT
AGREEMENT TO LOAN AND SECURITY AGREEMENT  (this  “Consent”)
dated  as of  March  12,  2010  is by and  among  EXAMWORKS,  INC.,  a  Delaware
corporation (“Parent”), SOUTHWEST MEDICAL EXAMINATION SERVICES,
INC., a Texas  corporation,  THE RICWEL  CORPORATION,  an Ohio corporation,  CFO
MEDICAL  SERVICES,  LLC,  a New Jersey  limited  liability  company,  DIAGNOSTIC
IMAGING INSTITUTE,  INC., a Texas corporation,  RICWEL OF WEST VIRGINIA,  LLC, a
West Virginia limited liability company, PACIFIC BILLING SERVICES, INC., a Texas
corporation,  SET-ASIDE  SOLUTIONS,  LLC, a Delaware limited liability  company,
MARQUIS  MEDICAL  ADMINISTRATORS,  INC.,  a New York  corporation,  IME SOFTWARE
SOLUTIONS,   LLC,  a  Michigan  limited  liability   company,   FLORIDA  MEDICAL
SPECIALISTS, INC., a New Jersey corporation,  EXAMWORKS EVALUATIONS OF NEW YORK,
LLC, a New York limited liability  company,  and the subsidiaries of Parent that
may from time to time  hereafter  become  parties  hereto and the Loan Agreement
(the foregoing, together with Parent, individually,  “Borrower”
and  collectively,  “Borrowers”),  FIFTH  THIRD  BANK,  an Ohio
banking  corporation  in  its  capacity  as  administrative  agent  for  Lenders
identified    below    (together    with    its    successors    and    assigns,
“Administrative   Agent”),   and  FIFTH  THIRD  BANK,   in  its
individual    capacity,    and   BANK   OF    AMERICA,    N.A.    (collectively,
“Lenders”).

 RECITALS:

      WHEREAS, Borrowers, Administrative Agent and Lenders are parties to that certain Loan and Security Agreement dated as of December 18, 2009, as amended pursuant to certain consents and amendments among the parties hereto (as the same may be further amended, supplemented or modified from time to time, collectively with all such consents and amendments, the “Loan Agreement”); all capitalized terms used but not defined herein shall have the meanings ascribed thereto in the Loan Agreement; and

      WHEREAS, Borrower requests Administrative Agent to consent to certain matters as provided herein, and Borrower, Administrative Agent and Lenders desire to amend certain provisions of the Loan Agreement, in each case in accordance with, and subject to, the terms and conditions set forth herein.

      NOW, THEREFORE, for and in consideration of the mutual covenants and agreements contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto (intending to be legally bound) hereby agree as follows:

      1. Consent. Subject to the terms and conditions set forth in this Consent, and notwithstanding anything in the Financing Agreements to the contrary, from and after the Consent Effective Date, Administrative Agent and Lenders consent to (a) the issuance by Parent of a minimum of 146,627 and a maximum of 1,054,837 shares) of Series A Convertible Preferred Stock of Parent (the “Preferred Stock”), on the terms and conditions described in that

  certain   Confidential  Private  Placement
Memorandum,  dated  February 22, 2010 and the First  Supplement  dated March 10,
2010,  each in the form attached hereto as Exhibit A  (collectively,  the
“PPM”),  and  (b)  notwithstanding  Section  9.15  of the  Loan
Agreement,  (i) the amendment of  Parent’s  Certificate of Incorporation to
add the  Certificate of Designation  with respect to the Preferred  Stock in the
form  attached   hereto  as  Exhibit  B  (the   “Certificate   of
Designation”),   (ii)  the  amendment  of  Parent’s   shareholders
agreement   in   the   form   attached   hereto   as   Exhibit   C   (the
“Shareholders Agreement Amendment”) and (iii) the entering into
by Parent of an investor rights agreement with purchasers of the Preferred Stock
in the form attached  hereto as Exhibit D (the  “Investor  Rights
Agreement”).

      2. Amendments to Loan Agreement. Subject to the terms and conditions contained herein, the parties hereto hereby amend the Loan Agreement as follows:

          a. Section 1.1 of the Loan Agreement is hereby amended as follows:

        i. the definition of “Change of Control” therein is hereby amended by changing the reference to “thirty-five percent (35%)” in clause (i) thereof to “twenty-five percent (25%)”.

        ii. the definition of “Consolidated Net Income” therein is hereby amended by adding the following immediately prior to the period at the end of such definition: “; provided, however, that for the avoidance of doubt the penalty payments described Section 2.1 of the Investor Rights Agreement shall be treated as expenses for purposes of calculating net income or net loss.”

           b. Section 1.1 of the Loan Agreement is hereby further amended by adding the following new defined terms in alphabetical order: 

        “Consent Effective Date” means March 12, 2010.

         “Investor Rights Agreement” means that certain investor rights agreement in the form attached as Exhibit D to the Consent to be entered into by Parent with the purchasers of the Preferred Stock.

       “Preferred Stock” means the Series A Convertible Preferred Stock of Parent.

           c. Section 7.1 of the Loan Agreement is hereby amended by changing the reference to “thirty-five percent (35%)” in the fourth sentence thereof to “twenty-five percent (25%)”.

           d. Section 9.9 of the Loan Agreement is hereby amended by deleting the word “and” immediately prior to clause (iii) therein and by adding the following immediately prior to the period at the end of such section: “and (iv) so long as no Default or Event of Default has occurred and is continuing or would result therefrom and Borrower is in compliance with the financial covenants set forth in Section 9.12 both immediately before and will be in compliance therewith after any such contemplated

 -2-

 action, Borrower will be permitted to pay the penalty payments described in Section 2.1 of the Investor Rights Agreement in cash.”

      3. No Other Consents or Amendments. Notwithstanding the consent and amendments set forth in Sections 1 and 2 hereof, Ultimate Parent and Borrowers acknowledge and expressly agree that this Consent is limited to the extent expressly set forth herein and shall not constitute a modification or further amendment of the Loan Agreement or any other Financing Agreements or a course of dealing at variance with the terms of the Loan Agreement or any other Financing Agreements (other than as expressly set forth in this Consent).

      4. Representations and Warranties. Ultimate Parent and each of Borrowers hereby represent and warrant to and in favor of the Administrative Agent and Lenders, which representations and warranties shall survive the execution and delivery hereof, as follows:

           a. Each representation and warranty set forth in Section 7 of the Loan Agreement is hereby restated and affirmed as true and correct in all material respects as of the date hereof, except to the extent previously fulfilled in accordance with the terms of the Loan Agreement, as amended hereby;

           b. Ultimate Parent and each of Borrowers has the company power and authority (i) to enter into this Consent and (ii) to do all acts and things as are required or contemplated hereunder to be done, observed and performed by it;

           c.  This Consent
has been duly  authorized,  validly  executed and  delivered by one or more Duly
Authorized  Officers of Ultimate Parent and each of Borrowers,  and each of this
Consent  and the  Loan  Agreement  constitutes  the  legal,  valid  and  binding
obligations of Borrowers (and each of this Consent and the Financing  Agreements
to which Ultimate  Parent is a party  constitutes  the legal,  valid and binding
obligations  of Ultimate  Parent),  enforceable  against  Borrowers and Ultimate
Parent, respectively,  in accordance with their respective terms, subject, as to
enforcement  of  remedies,  to the  following  qualifications:  (i) an  order of
specific  performance  and an  injunction  are  discretionary  remedies  and, in
particular, may not be available where damages are considered an adequate remedy
at  law  and  (ii)  enforcement  may  be  limited  by  bankruptcy,   insolvency,
liquidation,  reorganization,  reconstruction  and other similar laws  affecting
enforcement of creditors’ rights generally (insofar as any such law relates
to the  bankruptcy,  insolvency  or  similar  event of  Ultimate  Parent or such
Borrower);

           d. The execution and delivery of this Consent and performance by the Ultimate Parent and each of Borrowers under this Consent, the Loan Agreement and each of the other Financing Agreements to which each is a party do not and will not require the consent or approval of any regulatory authority or governmental authority or agency having jurisdiction over Ultimate Parent or any Borrower which has not already been obtained, nor be in contravention of or in conflict with the organizational documents of Ultimate Parent and each of Borrowers, or any provision of any statute, judgment, order, indenture, instrument, agreement, or undertaking, to which Ultimate Parent or any Borrower is party or by which Ultimate Parent’s or any Borrower’s assets or properties are bound;

 -3-

           e. No Default or Event of Default exists both before and after giving effect to this Consent, and no event has occurred that has had or could reasonably be expected to have a Material Adverse Effect; and

           f. The PPM, the Certificate of Designation, the Shareholders Agreement Amendment and the Investor Rights Agreement, in the forms attached hereto as exhibits, are true, correct and complete and have not been amended or modified in any respect.

      5. Conditions Precedent to Effectiveness of this Consent. The consent contained in Section 1 of this Consent shall become effective on the date hereof subject to:

           a. all of the representations and warranties of the Ultimate Parent and Borrowers under Section 4 hereof, which are made as of the date hereof, being true and correct in all material respects;

           b. receipt by Administrative Agent of duly executed signature pages to this Consent from the Ultimate Parent, each of Borrowers and Lenders;

           c. receipt by Administrative Agent of such duly executed and delivered resolutions, certified Organization Documents, good standing certificates, secretary’s certificate, and such other related certificates and documents (if any), reasonably required by Administrative Agent in connection with this Consent;

           d. receipt by Administrative Agent of true, correct and complete and duly executed copies of (or, to the extent the same are not executable documents or will not be executed until the closing of the sale of the Preferred Stock, final forms of) (i) the PPM, (ii) the Certificate of Designation, (iii) the Shareholders Agreement Amendment and (iv) the Investor Rights Agreement, and none of such documents shall be amended or modified in any way without the prior written consent of Administrative Agent;

           e. receipt by Administrative Agent of the amount of the reasonable fees and out-of-pocket costs and expenses of counsel to Administrative Agent in connection with this Consent and the transactions and documents contemplated hereby pursuant to Section 9 hereof and otherwise due and owing pursuant to the Loan Agreement; and

           f. receipt by Administrative Agent of such other assurances, certificates, schedules, exhibits, documents, consents or opinions as Administrative Agent or the Required Lenders reasonably may require.

      6. Financing Agreement. This Consent shall constitute a Financing Agreement.

      7. Reaffirmation; References to Loan Agreement.

           a. Each Borrower and Ultimate Parent acknowledges and agrees that all of their respective obligations and Liabilities under the Loan Agreement, as amended hereby,

 -4-

 shall be valid and enforceable and shall not be impaired or limited by the execution or effectiveness of this Consent.

           b. Upon the effectiveness of this Consent, each reference in the Loan Agreement to “this Agreement,” “hereunder,” “hereof,” “herein” or words of like import shall mean and be a reference to the Loan Agreement, as amended by this Consent.

           c. The failure by Administrative Agent, at any time or times hereafter, to require strict performance by any Borrower of any provision or term of the Loan Agreement, this Consent or any of the Financing Agreements shall not waive, affect or diminish any right of Administrative Agent hereafter to demand strict compliance and performance herewith or therewith. Any suspension or waiver by Administrative Agent of a breach of this Consent or any Event of Default under the Loan Agreement shall not, except as expressly set forth in a writing signed by Administrative Agent (and, if applicable, Required Lenders), suspend, waive or affect any other breach of this Consent or any Event of Default under the Loan Agreement, whether the same is prior or subsequent thereto and whether of the same or of a different kind or character. None of the undertakings, agreements, warranties, covenants and representations of any Borrower conta
ined in this Consent,
shall be deemed to have been suspended or waived by Administrative Agent unless such suspension or waiver is (i) in writing and signed by Administrative Agent and (ii) delivered to Parent. In no event shall Administrative Agent's execution and delivery of this Consent establish a course of dealing among Administrative Agent, Ultimate Parent, Parent or any other Borrower or any other obligor, or in any other way obligate Administrative Agent to hereafter provide any consents or amendments or, if at any time applicable, waivers with respect to the Loan Agreement. The terms and provisions of this Consent shall be limited precisely as written and shall not be deemed (x) to be a consent to any amendment or modification of any other term or condition of the Loan Agreement or of any of the Financing Agreements (except as expressly provided herein); or (y) to prejudice any right or remedy which Administrative Agent may now have under or in connection with the Loan Agreement or any of the Financing
Agreements.

           d. Except as expressly provided herein, the Loan Agreement and all Financing Agreements shall remain unaltered and in full force and effect and are hereby ratified and confirmed in all respects.

      8. Release.

           a. In consideration of, among other things, the consents and amendments provided for herein, and for other good and valuable consideration, as of the date hereof, the Ultimate Parent, Parent and each other Borrower (on behalf of themselves and their respective Subsidiaries and Affiliates), their successors-in-title, legal representatives and assignees and, to the extent the same is claimed by right of, through or under the above, for their past, present and future employees, members, managers, partners, agents, representatives, officers, directors, shareholders and trustees (all collectively, with Ultimate Parent, Parent and each other Borrower, the “Releasing Parties”), do hereby unconditionally and forever remise, satisfy, acquit, release and discharge the Administrative Agent and Lenders and any of their respective successors-in-title, legal representatives and assignees, past, present and future
officers,

 -5-

 directors, shareholders, trustees, agents, employees, consultants, experts, advisors, attorneys and other professionals and all other persons and entities to whom any of the Administrative Agent and Lenders would be liable if such persons or entities were found in any way to be liable to any of the Releasing Parties (collectively hereinafter the “Lender Parties”), from any and all manner of action and actions, cause and causes of action, claims, cross-claims, charges, demands, counterclaims, suits, debts, dues, sums of money, accounts, reckonings, bonds, bills, specialties, covenants, contracts, controversies, damages, judgments, liabilities, damages, expenses, executions, liens, claims of liens, claims of costs, penalties, attorneys' fees, or any other compensation, recovery or relief on account of any liability, obligation, demand or cause of action of whatever nature, whether in law, equity or otherwise (including, without limitation, those arising
under 11 U.S.C. §§ 541-550 and interest or other carrying costs, penalties, legal, accounting and other professional fees and expenses, and incidental, consequential and punitive damages payable to third parties), whether known or unknown, fixed or contingent, joint and/or several, secured or unsecured, due or not due, primary or secondary, liquidated or unliquidated, contractual or tortious, direct, indirect, or derivative, asserted or unasserted, foreseen or unforeseen, suspected or unsuspected, now existing, heretofore existing or which may have heretofore accrued against any or all of the Lender Parties, whether held in a personal or representative capacity, and which are based on any act, fact, event or omission or other matter, cause or thing occurring at or from any time prior to and including the date hereof in any way, directly or indirectly arising out of, connected with or relating to this Consent, the Loan Agreement or any other Financing Agreement and the transactions
contemplated hereby and thereby, and all other agreements, certificates, instruments and other documents and statements (whether written or oral) related to any of the foregoing. Borrower, Parent and Ultimate Parent acknowledge that Administrative Agent is specifically relying upon the representations, warranties and agreements contained herein and that such representations, warranties and agreements constitute a material inducement to Administrative Agent in entering into this Consent.

           b. Each of the Ultimate Parent, Parent and each other Borrower hereby knowingly, voluntarily, intentionally and expressly waives and relinquishes any and all rights and benefits that it may have as against the Lender Parties under any law, rule or regulation of any jurisdiction that would have the effect of limiting the extent to which a general release extends to claims which a Lender Party or Releasing Party does not know or suspect to exist as of the date hereof. Each of the Ultimate Parent, Parent and each other Borrower hereby acknowledges that the waiver set forth in the prior sentence was separately bargained for and that such waiver is an essential term and condition of this Consent (and without which the consent in Section 1 hereof would not have been given by Administrative Agent and Lenders).

      9. Costs, Expenses and Taxes. Without limiting the obligation of Borrowers to reimburse Administrative Agent for all costs, fees, disbursements and expenses incurred by Administrative Agent as specified in the Loan Agreement, as amended by this Consent, each Borrower agrees to pay on demand all costs, fees, disbursements and expenses of Administrative Agent in connection with the preparation, negotiation, revision, execution and delivery of this Consent and the other agreements, instruments and documents contemplated hereby, including, without limitation, reasonable attorneys' fees and out-of-pocket expenses.

 -6-

      10. Counterparts. This Consent may be executed in multiple counterparts, each of which shall be deemed to be an original and all of which when taken together shall constitute one and the same agreement.

      11. Governing Law. This Consent shall be deemed to be made pursuant to the laws of the State of Illinois and shall be construed, interpreted, governed performed and enforced in accordance therewith, without regard to conflict of law principles.

      12. Severability; Faxes. Any provision of this Consent which is prohibited or unenforceable for any reason shall be ineffective solely to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof in that jurisdiction or affecting the validity or enforceability of such provision in any other jurisdiction. A signature hereto sent or delivered by facsimile or other electronic transmission shall be as legally binding and enforceable as a signed original for all purposes.

      13. Successors and Assigns. This Consent shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns; provided, however, neither Ultimate Parent, Parent nor any Borrower may assign any of its respective rights or obligations under this Consent without the prior written consent of Administrative Agent.

 [Remainder of page intentionally blank; signature pages follow]

 -7-

      IN WITNESS WHEREOF, the parties hereto have executed this Consent Agreement to Loan and Security Agreement as of the day and year first above written.

			
	      	 EXAMWORKS, INC.
	  
	 	 By:	       /s/ J. Miguel Fernandez
      de Castro
      

    
	 	 Name: J. Miguel Fernandez de Castro
	 	 Its: Senior Vice President and Chief Financial
	 	 Officer
	 	  
	 	 SOUTHWEST MEDICAL EXAMINATION
	 	    SERVICES,
      INC.
	 	 THE RICWEL CORPORATION
	 	 DIAGNOSTIC IMAGING INSTITUTE, INC.
	 	 PACIFIC BILLING SERVICES, INC.
	 	 MARQUIS MEDICAL ADMINISTRATORS, INC.
	 	 FLORIDA MEDICAL SPECIALISTS, INC.
	 	  
	 	 By:	       /s/ J. Miguel Fernandez
      de Castro
      

    
	 	 Name: J. Miguel Fernandez de Castro
	 	 Its: Senior Vice President and Chief Financial
	 	 Officer
	 	  
	 	 CFO MEDICAL SERVICES, LLC
	 	 RICWEL OF WEST VIRGINIA, LLC
	 	  
	 	 By: ExamWorks, Inc., its sole member and manager
	 	  
	 	 By:	       /s/ J. Miguel Fernandez
      de Castro
      

    
	 	 Name: J. Miguel Fernandez de Castro
	 	 Its: Senior Vice President and Chief Financial
	 	 Officer
	 	  
	 	 SET-ASIDE SOLUTIONS, LLC
	 	 IME SOFTWARE SOLUTIONS, LLC
	 	EXAMWORKS EVALUATIONS OF NEW YORK, LLC
	 	  
	 	 By: ExamWorks, Inc., its sole member
	 	  
	 	 By:	       /s/ J. Miguel Fernandez
      de Castro
      

    
	 	 Name: J. Miguel Fernandez de Castro
	 	 Its: Senior Vice President and Chief Financial
	 	 Officer

 EXAMWORKS, INC.

CONSENT AGREEMENT TO LOAN AND SECURITY AGREEMENT

		
	 Acknowledged and Agreed:
	  
	 EXAMWORKS HOLDINGS, LLLP
	 By: Compass Partners, L.L.C., its General Partner
	  
	 By:     	       /s/ Richard E. Perlman
      

    
	 Name: Richard E. Perlman
	 Its: President

 EXAMWORKS, INC.

CONSENT AGREEMENT TO LOAN AND SECURITY AGREEMENT

			
	     	 FIFTH THIRD BANK,
	 	 as Administrative Agent and a Lender
	 	  	 
	 	 By:	       /s/
      Philip Renwick
      

    
	 	  	 Philip Renwick
	 	  	 Vice President
	 	  	 
	 	  	 
	 	 BANK OF AMERICA, N.A.,
	 	 as a Lender
	 	  	 
	 	 By:	       /s/
      Shawn Janko
      

    
	 	  	 Shawn Janko
	 	  	 Senior Vice President

 EXAMWORKS, INC.

CONSENT AGREEMENT TO LOAN AND SECURITY AGREEMENT

 

 EXHIBIT B

  to Consent Agreement to Loan and Security Agreement

 Certificate of Designation

 (see attached)

 EXAMWORKS, INC.

 AMENDED

  CERTIFICATE OF DESIGNATION

  establishing the

  Voting Powers, Designations, Preferences, Limitations,

  Restrictions and Relative Rights

  of

  Series A Convertible Preferred Stock

  of

  ExamWorks, Inc.

 Pursuant to Section 151 of the

  Delaware General Corporation Law

      ExamWorks, Inc., a corporation organized and
  existing under the General Corporation Law of the State of Delaware (the “Corporation”),
  in accordance with the provisions of Sections 103 and 151 thereof, DOES HEREBY
  CERTIFY:

      That pursuant to the authority vested in the
  Board of Directors of the Corporation (the “Board of Directors”)
  in accordance with the provisions of Article IV of the Amended and Restated
  Certificate of Incorporation of the Corporation (the “Certificate of
  Incorporation”), the Board of Directors duly adopted the following
  resolution on March 8, 2010 creating a series of 1,054,837 shares of Preferred
  Stock, designated as “Series A Convertible Preferred Stock”:

      RESOLVED, that pursuant to the authority vested
  in the Board of Directors in accordance with the provisions of the Certificate
  of Incorporation, a series of Preferred Stock, par value $0.0001 per share,
  of the Corporation be and hereby is created, and that the designation and number
  of shares thereof, and the voting and other powers, preferences and other rights
  of the shares of such series, and the qualifications, limitations and restrictions
  thereof, are as follows:

 SERIES A CONVERTIBLE PREFERRED STOCK

      A. Designation and Amount. The designation
  of this series of convertible preferred stock shall be 1,054,837 shares of “Series
  A Convertible Preferred Stock,” with a par value of $0.0001 per share
  (hereinafter called the “Series A Stock”).

      B. Rights, Preferences, Privileges and Restrictions
  of Series A Stock. The rights, preferences, privileges and restrictions
  granted to and imposed on the Series A Stock are as follows:

           1. Dividend
  Provisions.

                1.1.
  Commencing on the earlier of (i) the date on which at least 967,741 shares of
  the Series A Stock are issued by the Corporation or (ii) May 24, 2010 (such

 2

 date, the “Termination Date”), the holders of shares of Series
  A Stock shall be entitled to receive, prior and in preference to the declaration
  or payment of any dividend or distribution to the holders of the Corporation’s
  common stock, par value $0.0001 per share (the “Common Stock”)
  or any other shares or securities of the Corporation ranking junior to the Series
  A Stock with respect to the payment of dividends or the distribution of assets
  on liquidation (“Junior Securities”) dividends which shall
  accrue at a rate per annum (computed on the basis of a 365-day year for the
  actual number of days elapsed) of twelve percent (12%) of the Original Price
  (as defined below), compounded annually (whether or not earned or declared);
  provided, however, that dividends shall stop accruing as of the Redemption Date
  (as defined below) with respect to any and all shares for which the Corporation
  has deposited the Redemption Price (as defined below) on or before the Redemption
  Date pursuant to Section B.3.4. hereof. Dividends under this Section B.1.1.
  shall only be payable (i) in the event of a Liquidation Event or Deemed Liquidation
  Event (each as defined below) or (ii) in the event the Series A Stock is redeemed
  pursuant to Section B.3. below. The “Original Issue Price”
  shall mean $34.10 per share of Series A Stock, subject to appropriate adjustment
  in the event of any stock dividend, stock split, combination or other similar
  recapitalization with respect to the Series A Stock.

                1.2.
  In addition to and not in limitation of the dividends provided for in Section
  B.1.1., the holders of Series A Stock shall first receive, or simultaneously
  receive, dividends and other distributions equivalent to those declared or paid
  on Common Stock or any other Junior Securities, determined as if the Series
  A Stock had been converted into Common Stock at the then effective Conversion
  Price (as defined below) (or, in the case of dividends or distributions on securities
  other than Common Stock, determined on a comparable basis), and payable when,
  as and if declared by the Board of Directors on such Common Stock or other Junior
  Securities.

                1.3.
  Notwithstanding anything herein to the contrary, in no event shall holders of
  Series A Stock receive any dividends or distributions in a lesser amount than
  the amount received by holders of any Junior Securities or less than they would
  have received if they had converted such Series A Stock into Common Stock immediately
  prior to such dividend or distribution (other than dividends or distributions
  payable solely in shares of Common Stock as part of a stock split).

                1.4.
  The repurchase, redemption or other acquisition or retirement for value of any
  shares of capital stock of the Corporation deemed to occur upon the exercise
  or exchange of stock options, warrants or other similar rights to the extent
  such shares of capital stock represent a portion of the exercise or exchange
  price of those stock options, warrants or similar rights, and the repurchase,
  redemption or other acquisition or retirement of shares of capital stock made
  in lieu of withholding taxes resulting from the exercise or exchange of stock
  options, warrants or other similar rights, shall not constitute a dividend for
  purposes of this Section B.1.

           2. Liquidation
  Preference.

                2.1.
  Payments to Holders of Series A Preferred Stock. In the event of any
  voluntary or involuntary liquidation, dissolution or winding up of the Corporation
  (each, a “Liquidation Event”), the holders of shares of Series
  A Stock then outstanding shall be entitled to

 3

 be paid out of the assets of the Corporation available for distribution to
  its stockholders before any payment shall be made to the holders of Common Stock
  or any other Junior Securities by reason of their ownership thereof, an amount
  per share equal to the greater of (i) one (1) times the Original Issue Price,
  plus any accrued and unpaid dividends and any other dividends declared but unpaid
  thereon, or (ii) such amount per share as would have been payable had all shares
  of Series A Stock been converted into Common Stock pursuant to Section B.4.
  immediately prior to such Liquidation Event (the amount payable pursuant to
  this sentence is hereinafter referred to as the “Series A Liquidation
  Amount”). If upon any such Liquidation Event, the assets of the Corporation
  available for distribution to its stockholders shall be insufficient to pay
  the holders of shares of Series A Stock the full amount to which they shall
  be entitled under this Section B.2.1., the holders of shares of Series A Stock
  shall share ratably in any distribution of the assets available for distribution
  in proportion to the respective amounts which would otherwise be payable in
  respect of the shares held by them upon such distribution if all amounts payable
  on or with respect to such shares were paid in full.

                2.2.
  Payments to Holders of Common Stock. In the event of any Liquidation
  Event, after the payment of all preferential amounts required to be paid to
  the holders of shares of Series A Stock, the remaining assets of the Corporation
  available for distribution to its stockholders shall be distributed among the
  holders of shares of Common Stock and Junior Securities, pro rata based on the
  number of shares held by each such holder, as applicable, in accordance with
  their respective terms.

                2.3.
  Deemed Liquidation Events.

                          (a)
  Definition. Each of the following events shall be considered a “Deemed
  Liquidation Event”:

                               (i)
  a merger or consolidation in which the Corporation is a constituent party; except
  any such merger or consolidation in which the shares of capital stock of the
  Corporation outstanding immediately prior to such merger or consolidation continue
  to represent, or are converted into or exchanged for shares of capital stock
  that represent, immediately following such merger or consolidation, at least
  a majority, by voting power, of the capital stock of (1) the surviving or resulting
  corporation or (2) if the surviving or resulting corporation is a wholly owned
  subsidiary of another company immediately following such merger or consolidation,
  the parent company of such surviving or resulting corporation (provided,
  that, for the purpose of this Section B.2.3.(a)(i), all shares of Common
  Stock issuable upon exercise of options, warrants or similar rights outstanding
  immediately prior to such merger or consolidation or upon conversion of the
  Series A Stock outstanding immediately prior to such merger or consolidation
  shall be deemed to be outstanding immediately prior to such merger or consolidation
  and, if applicable, converted or exchanged in such merger or consolidation on
  the same terms as the actual outstanding shares of Common Stock are converted
  or exchanged); or

                               (ii)
  the sale, lease, transfer or other disposition, in a single transaction or series
  of related transactions, by the Corporation of all or substantially all the
  assets of the Corporation, except where such sale, lease, transfer or other
  disposition is to a majority-owned subsidiary of the Corporation.

 4

                2.4.
  Effecting a Deemed Liquidation Event.

                          (a)
  The Corporation shall not have the power to effect a Deemed Liquidation Event
  referred to in Section B.2.3.(a)(i) unless the agreement or plan of merger or
  consolidation for such transaction provides that the consideration payable to
  the stockholders of the Corporation shall be allocated among the holders of
  capital stock of the Corporation in accordance with Sections B.2.1. and B.2.2.

                          (b)
  In the event of a Deemed Liquidation Event referred to in Section B.2.3.(a)(ii),
  if the Corporation does not effect a dissolution of the Corporation under the
  Delaware General Corporation Law within 90 days after such Deemed Liquidation
  Event, then (y) the Corporation shall send a written notice to each holder of
  Series A Stock no later than the 90th day after the Deemed Liquidation Event
  advising such holders of their right (and the requirements to be met to secure
  such right) pursuant to the terms of the following clause (z) to require the
  redemption of such shares of Series A Stock, and (z) the Corporation shall use
  the consideration received by the Corporation for such Deemed Liquidation Event
  (net of any retained liabilities associated with the assets sold, leased, transferred
  or otherwise disposed of, as determined in good faith by the Board of Directors
  of the Corporation), together with any other assets of the Corporation available
  for distribution to its stockholders (the “Available Proceeds”),
  to the extent legally available therefor, on the 150th day after such Deemed
  Liquidation Event, to redeem all outstanding shares of Series A Stock at a price
  per share equal to the Series A Liquidation Amount. Notwithstanding the foregoing,
  in the event of a redemption pursuant to the preceding sentence, if the Available
  Proceeds are not sufficient to redeem all outstanding shares of Series A Stock,
  the Corporation shall redeem a pro rata portion of each holder’s shares
  of Series A Stock to the fullest extent of such Available Proceeds, based on
  the respective amounts which would otherwise be payable in respect of the shares
  to be redeemed if the Available Proceeds were sufficient to redeem all such
  shares, and shall redeem the remaining shares to have been redeemed as soon
  as practicable after the Corporation has funds legally available therefor. The
  provisions of Section B.3. shall apply, with such necessary changes in the details
  thereof as are necessitated by the context, to the redemption of the Series
  A Stock pursuant to this Section B.2.4.(b). Prior to the distribution or redemption
  provided for in this Section B.2.4.(b), the Corporation shall not expend, transfer
  or dissipate the consideration received for such Deemed Liquidation Event, except
  to discharge expenses incurred in connection with such Deemed Liquidation Event
  or in the ordinary course of business.

                2.5.
  Amount Deemed Paid or Distributed. The amount deemed paid or distributed
  to the holders of capital stock of the Corporation upon any Liquidation Event
  or Deemed Liquidation Event shall be the cash or the value of the property,
  rights or securities paid or distributed to such holders by the Corporation
  or the acquiring person, firm or other entity. The value of such property, rights
  or securities shall be determined in good faith by the Board of Directors of
  the Corporation.

           3. Redemption
  Rights.

                3.1.
  The Corporation shall have the right at any time, and from time to time, during
  the Redemption Period (as defined below) to redeem all, and not less than all,
  of the outstanding shares of Series A Stock (the “Redemption Shares”)
  at a per share price (the

 5

 “Redemption Price”) in cash equal to the Conversion Price
  as of the Redemption Date (as defined below) multiplied by 1.75.

                3.2.
  The redemption right set forth in Section B.3.1. above shall be exercised by
  the Corporation by providing written notice of such redemption (the “Redemption
  Notice”) to each holder of record (as of the close of business on the
  business day preceding the date of the Redemption Notice) of shares of Series
  A Stock at the address last shown on the records of the Corporation for such
  holder or given by the holder to the Corporation for the purpose of notice,
  at least 30 days, but no more than 60 days prior to the date on which such redemption
  shall take place (“Redemption Date”). The Redemption Notice
  shall specify the number of shares that will be redeemed, the Redemption Price,
  the place at which payment may be obtained for redeemed shares and such other
  information as the Corporation may deem advisable to provide regarding the redemption
  of the Redemption Shares.

                3.3.
  Three days prior to the Redemption Date, the Corporation shall deposit the Redemption
  Price for all Redemption Shares not yet redeemed or converted, with a bank or
  trust company having aggregate capital and surplus in excess of $500,000,000
  as a trust fund for the benefit of the respective holders of the shares designated
  for redemption and not yet redeemed or converted. Simultaneously, the Corporation
  shall deposit irrevocable instructions and authority with such bank or trust
  company to pay, on and after the Redemption Date, the Redemption Price of the
  Redemption Shares to the holders thereof upon surrender of their certificates.
  The balance of any monies deposited by the Corporation pursuant to this paragraph
  remaining unclaimed at the expiration of six months following the Redemption
  Date shall thereafter be returned to the Corporation, provided that the stockholder
  to whom such monies would be payable hereunder shall be entitled to receive
  such monies upon proof of ownership of the Series A Stock.

                3.4.
  The “Redemption Period” shall mean any time on or after the
  third anniversary of the Termination Date and prior to the consummation of a
  Liquidation Event, Deemed Liquidation Event or Qualified Public Offering (as
  defined below).

           4. Optional
  Conversion.

           The holders of
  Series A Stock shall have conversion rights as follows (the “Conversion
  Rights”):

                4.1.
  Right to Convert.

                     (a)
  Conversion Ratio. Each share of Series A Stock shall be convertible,
  at the option of the holder thereof at any time after the date of issuance of
  such share, in each case at the office of the Corporation or any transfer agent
  for the Series A Stock, into such number of fully paid and nonassessable shares
  of Common Stock as is determined by dividing the Original Issue Price by the
  Conversion Price at the time in effect for such shares. The initial “Conversion
  Price” per share for shares of Series A Stock shall be the Original
  Issue Price; provided, however, such Conversion Price and the rate at which
  shares of Series A Stock may be converted into shares of Common Stock, shall
  be subject to adjustment as provided below.

 6

                     (b)
  Termination of Conversion Rights. In the event of a notice of redemption
  of any shares of Series A Stock pursuant to Section B.3., the Conversion Rights
  of the shares designated for redemption shall terminate at the close of business
  on the last full day preceding the Redemption Date, unless the Redemption Price
  is not fully paid on such Redemption Date, in which case the Conversion Rights
  for such shares shall continue until such price is paid in full. In the event
  of a Liquidation Event or a Deemed Liquidation Event, the Conversion Rights
  shall terminate at the close of business on the last full day preceding the
  date fixed for the payment of any such amounts distributable on such event to
  the holders of Series A Stock.

                4.2.
  Fractional Shares. No fractional shares of Common Stock shall be issued
  upon conversion of the Series A Stock. In lieu of any fractional shares to which
  the holder would otherwise be entitled, the Corporation shall pay cash equal
  to such fraction multiplied by the fair market value of a share of Common Stock
  as determined in good faith by the Board of Directors of the Corporation.

                4.3.
  Mechanics of Conversion.

                     (a)
  Notice of Conversion. In order for a holder of Series A Stock to voluntarily
  convert shares of Series A Stock into shares of Common Stock, such holder shall
  surrender the certificate or certificates for such shares of Series A Stock
  (or, if such registered holder alleges that such certificate has been lost,
  stolen or destroyed, a lost certificate affidavit and agreement reasonably acceptable
  to the Corporation to indemnify the Corporation against any claim that may be
  made against the Corporation on account of the alleged loss, theft or destruction
  of such certificate), at the office of the transfer agent for the Series A Stock
  (or at the principal office of the Corporation if the Corporation serves as
  its own transfer agent), together with written notice that such holder elects
  to convert all or any number of the shares of the Series A Stock represented
  by such certificate or certificates and, if applicable, any event on which such
  conversion is contingent. Such notice shall state such holder’s name or
  the names of the nominees in which such holder wishes the certificate or certificates
  for shares of Common Stock to be issued. If required by the Corporation, certificates
  surrendered for conversion shall be endorsed or accompanied by a written instrument
  or instruments of transfer, in form reasonably satisfactory to the Corporation,
  duly executed by the registered holder or his, her or its attorney duly authorized
  in writing. The close of business on the date of receipt by the transfer agent
  (or by the Corporation if the Corporation serves as its own transfer agent)
  of such certificates (or lost certificate affidavit and agreement) and notice
  shall be the time of conversion (the “Conversion Time”), and
  the shares of Common Stock issuable upon conversion of the shares represented
  by such certificate shall be deemed to be outstanding of record as of such date.
  The Corporation shall, as soon as practicable after the Conversion Time, (i)
  issue and deliver to such holder of Series A Stock, or to his, her or its nominees,
  a certificate or certificates for the number of full shares of Common Stock
  issuable upon such conversion in accordance with the provisions hereof and a
  certificate for the number (if any) of the shares of Series A Stock represented
  by the surrendered certificate that were not converted into Common Stock, (ii)
  pay in cash such amount as provided in Section B.4.2 in lieu of any fraction
  of a share of Common Stock otherwise issuable upon such conversion and (iii)
  pay any declared but unpaid dividends that such holder is entitled to pursuant
  to Section B.1.2.

 7

                     (b)
  Reservation of Shares. The Corporation shall at all times when the Series
  A Stock shall be outstanding, reserve and keep available out of its authorized
  but unissued capital stock, for the purpose of effecting the conversion of the
  Series A Stock, such number of its duly authorized shares of Common Stock as
  shall from time to time be sufficient to effect the conversion of all outstanding
  Series A Stock; and if at any time the number of authorized but unissued shares
  of Common Stock shall not be sufficient to effect the conversion of all then
  outstanding shares of the Series A Stock, the Corporation shall take such corporate
  action as may be necessary to increase its authorized but unissued shares of
  Common Stock to such number of shares as shall be sufficient for such purposes,
  including, without limitation, engaging in best efforts to obtain the requisite
  stockholder approval of any necessary amendment to the Certificate of Incorporation.
  Before taking any action which would cause an adjustment reducing the Conversion
  Price below the then par value of the shares of Common Stock issuable upon conversion
  of the Series A Stock, the Corporation will take any corporate action which
  may, in the opinion of its counsel, be necessary in order that the Corporation
  may validly and legally issue fully paid and nonassessable shares of Common
  Stock at such adjusted Conversion Price.

                     (c)
  Effect of Conversion. All shares of Series A Stock which shall have been
  surrendered for conversion as herein provided shall no longer be deemed to be
  outstanding and all rights with respect to such shares shall immediately cease
  and terminate at the Conversion Time, except only the right of the holders thereof
  to receive shares of Common Stock in exchange therefor, to receive payment in
  lieu of any fraction of a share otherwise issuable upon such conversion as provided
  in Section B.4.2. and to receive payment of any dividends declared but unpaid
  that such holder is entitled to pursuant to Section B.1.2. Any shares of Series
  A Stock so converted shall be retired and cancelled and may not be reissued
  as shares of such series, and the Corporation may thereafter take such appropriate
  action (without the need for stockholder action) as may be necessary to reduce
  the authorized number of shares of Series A Stock accordingly.

                     (d)
  No Further Adjustment. Upon any such conversion, no adjustment to the
  Conversion Price shall be made for any accrued and unpaid or declared but unpaid
  dividends on the Series A Stock surrendered for conversion or on the Common
  Stock delivered upon conversion.

                     (e)
  Taxes. The Corporation shall pay any and all issue and other similar
  taxes that may be payable in respect of any issuance or delivery of shares of
  Common Stock upon conversion of shares of Series A Stock pursuant to this Section
  B.4. The Corporation shall not, however, be required to pay any tax which may
  be payable in respect of any transfer involved in the issuance and delivery
  of shares of Common Stock in a name other than that in which the shares of Series
  A Stock so converted were registered, and no such issuance or delivery shall
  be made unless and until the person or entity requesting such issuance has paid
  to the Corporation the amount of any such tax or has established, to the satisfaction
  of the Corporation, that such tax has been paid.

                     (f)
  Qualified Public Offering. Notwithstanding anything herein to the contrary,
  if a conversion notice is delivered to the Corporation following the filing
  of a registration statement with the Securities and Exchange Commission in connection
  with a

 8

 Qualified Public Offering, the conversion may, at the option of the Company,
  be conditioned upon the closing of such Qualified Public Offering, in which
  event the person(s) entitled to receive the shares issuable upon such conversion
  shall not be deemed to have converted such shares until following the closing
  of such Qualified Public Offering pursuant to Section B.5.

                4.4.
  Adjustments to Conversion Price of Series A Stock for Certain Diluting Issues.

                     (a)
  Special Definitions. For purposes of this Section B.4.4. the following
  definitions shall apply:

                          (i)
  “Options” shall mean rights, options or warrants to subscribe
  for, purchase or otherwise acquire either Common Stock or Convertible Securities
  (as defined below).

                          (ii)
  “Convertible Securities” shall mean any evidence of indebtedness,
  shares or other securities directly or indirectly convertible into or exchangeable
  for Common Stock.

                          (iii)
  “Additional Shares of Common Stock” shall mean all Common Stock
  issued (or, pursuant to subsection B.4.4.(c), deemed to be issued) by the Corporation
  after the Termination Date, other than (1) the following shares of Common Stock
  and (2) shares of Common Stock deemed issued pursuant to the following Options
  and Convertible Securities (clauses (1) and (2), collectively, “Exempted
  Securities”):

                            (A)
    Series A Stock and shares of Common Stock, Options or Convertible Securities
    issued upon conversion of or as a dividend or distribution on the Series A
    Stock;

                            (B)
    shares of Common Stock, Options or Convertible Securities issued to officers,
    directors or employees of, or consultants, advisors or agents to, the Corporation
    or any of its subsidiaries pursuant to stock agreements, purchase plans, employee
    incentive programs, stock options or warrants approved by the Board of Directors
    of the Corporation; provided, however, that the price or exercise or conversion
    price for such securities, as applicable, shall not be less than fair market
    value at the time of issuance, as determined in good faith by the Board of
    Directors of the Corporation and such issuances shall not exceed the greater
    of (i) the number of shares of Common Stock reserved for issuance under the
    Corporation’s 2008 Stock Option Plan and (ii) collectively with the issuances
    under Section B.4.4.(a)(iii)(F), (G) and (H) in the aggregate, twenty percent
    (20%) of the then outstanding shares of Common Stock (treating for this purpose
    as outstanding all shares of Common Stock issuable upon exercise of Options
    outstanding immediately prior to such issue or upon conversion or exchange
    of Convertible Securities (including the Series A Stock) outstanding (assuming
    exercise of any outstanding Options therefor) immediately prior to such issuance);

                            (C)
    shares of Common Stock or Convertible Securities actually issued upon the
    exercise of Options or shares of Common Stock

 9

   actually issued upon the conversion or exchange of Convertible Securities,
    in each case provided such issuance is pursuant to the terms of such Option
    or Convertible Security;

                            (D)
    shares of Common Stock, Options or Convertible Securities issued by reason
    of a dividend, stock split, split-up or other distribution of shares of Common
    Stock that is covered by Sections B.4.5., B.4.6., B.4.7. or B.4.8. below;

                            (E)
    shares of Common Stock, Options or Convertible Securities issued as all or
    part of the consideration for the acquisition (whether by merger or otherwise)
    by the Corporation of stock or assets of any other entity in a transaction
    approved by the Board of Directors;

                            (F)
    shares of Common Stock, Options or Convertible Securities issued to banks,
    equipment lessors or other financial institutions, or to real property lessors,
    pursuant to a debt financing, equipment leasing or real property leasing transaction
    approved by the Board of Directors of the Corporation; provided, however,
    that such issuance, collectively with the issuances under Section B.4.4.(a)(iii)(G)
    and (H) in the aggregate, does not exceed twenty percent (20%) of the then
    outstanding shares of Common Stock (treating for this purpose as outstanding
    all shares of Common Stock issuable upon exercise of Options outstanding immediately
    prior to such issue or upon conversion or exchange of Convertible Securities
    (including the Series A Stock) outstanding (assuming exercise of any outstanding
    Options therefor) immediately prior to such issuance);

                            (G)
    shares of Common Stock, Options or Convertible Securities issued to suppliers
    or third party service providers in connection with the provision of goods
    or services pursuant to transactions approved by the Board of Directors of
    the Corporation; provided, however, (x) that the price or exercise or conversion
    price for such securities, as applicable, shall not be less than fair market
    value at the time of issuance, as determined in good faith by the Board of
    Directors of the Corporation and (y) such issuances, collectively with the
    issuances under Section B.4.4.(a)(iii)(B), (F) and (H) in the aggregate, does
    not exceed twenty percent (20%) of the then outstanding shares of Common Stock
    (treating for this purpose as outstanding all shares of Common Stock issuable
    upon exercise of Options outstanding immediately prior to such issue or upon
    conversion or exchange of Convertible Securities (including the Series A Stock)
    outstanding (assuming exercise of any outstanding Options therefor) immediately
    prior to such issuance);

                           (H)
    shares of Common Stock, Options or Convertible Securities issued pursuant
    to any transaction determined by the Board of Directors to be strategic; provided,
    however, that (x) such issuance is approved by the Board of Directors, (y)
    such issuance is not for the principal purpose of raising equity capital and
    (z) such issuance, collectively with the issuances under Section B.4.4.(a)(iii)(B),
    (F) and (G) in the aggregate, does not exceed twenty percent (20%) of the
    then outstanding shares of Common Stock (treating for this purpose as outstanding
    all shares of Common Stock issuable upon exercise of Options outstanding immediately

 10

   prior to such issue or upon conversion or exchange of Convertible Securities
    (including the Series A Stock) outstanding (assuming exercise of any outstanding
    Options therefor) immediately prior to such issuance); and

                            (I)
    shares of Common Stock, Options or Convertible Securities issued pursuant
    to warrants issued to Broadband Capital Management LLC in connection with
    the private placement of the Series A Stock.

                          (b)
  No Adjustment of Conversion Price. No adjustment in the Conversion Price
  shall be made as the result of the issuance or deemed issuance of Additional
  Shares of Common Stock if the Corporation receives written notice from the holders
  of at least 66% of the then outstanding shares of Series A Stock agreeing that
  no such adjustment shall be made as the result of the issuance or deemed issuance
  of such Additional Shares of Common Stock.

                          (c)
  Deemed Issue of Additional Shares of Common Stock.

                               (i)
  If the Corporation at any time or from time to time after the Termination Date
  shall issue any Options or Convertible Securities (excluding Options or Convertible
  Securities which are themselves Exempted Securities) or shall fix a record date
  for the determination of holders of any class of securities entitled to receive
  any such Options or Convertible Securities, then the maximum number of shares
  of Common Stock (as set forth in the instrument relating thereto, assuming the
  satisfaction of any conditions to exercisability, convertibility or exchangeability
  but without regard to any provision contained therein for a subsequent adjustment
  of such number) issuable upon the exercise of such Options or, in the case of
  Convertible Securities and Options therefor, the conversion or exchange of such
  Convertible Securities, shall be deemed to be Additional Shares of Common Stock
  (unless the Common Stock issuable pursuant to such Options or Convertible Securities
  are themselves Exempted Securities) issued as of the time of such issue or,
  in case such a record date shall have been fixed, as of the close of business
  on such record date.

                               (ii)
  If the terms of any Option or Convertible Security, the issuance of which resulted
  in an adjustment to the Conversion Price pursuant to the terms of Section B.4.4.(d),
  are revised as a result of an amendment to such terms or any other adjustment
  pursuant to the provisions of such Option or Convertible Security (but excluding
  automatic adjustments to such terms pursuant to anti-dilution or similar provisions
  of such Option or Convertible Security) to provide for either (1) any increase
  or decrease in the number of shares of Common Stock issuable upon the exercise,
  conversion and/or exchange of any such Option or Convertible Security or (2)
  any increase or decrease in the consideration payable to the Corporation upon
  such exercise, conversion and/or exchange, then, effective upon such increase
  or decrease becoming effective, the Conversion Price computed upon the original
  issue of such Option or Convertible Security (or upon the occurrence of a record
  date with respect thereto) shall be readjusted to such Conversion Price as would
  have obtained had such revised terms been in effect upon the original date of
  issuance of such Option or Convertible Security. Notwithstanding the foregoing,
  no readjustment pursuant to this subclause (ii) shall have the effect of increasing
  the Conversion Price to an amount which exceeds the lower of (y) the Conversion
  Price in effect immediately prior to the original adjustment made as a result
  of the

 11

 issuance of such Option or Convertible Security, or (z) the Conversion Price
  resulting from any issuances of Additional Shares of Common Stock (other than
  deemed issuances of Additional Shares of Common Stock as a result of the issuance
  of such Option or Convertible Security) that occurred between the original adjustment
  date and such readjustment date.

                               (iii)
  If the terms of any Option or Convertible Security (excluding Options or Convertible
  Securities which are themselves Exempted Securities), the issuance of which
  did not result in an adjustment to the Conversion Price pursuant to the terms
  of Section B.4.4.(d) (either because the consideration per share (determined
  pursuant to Section B.4.4.(e)) of the Additional Shares of Common Stock subject
  thereto was equal to or greater than the Conversion Price then in effect, or
  because such Option or Convertible Security was issued before the Termination
  Date), are revised after the Termination Date as a result of an amendment to
  such terms or any other adjustment pursuant to the provisions of such Option
  or Convertible Security (but excluding automatic adjustments to such terms pursuant
  to anti-dilution or similar provisions of such Option or Convertible Security)
  to provide for either (1) any increase in the number of shares of Common Stock
  issuable upon the exercise, conversion or exchange of any such Option or Convertible
  Security or (2) any decrease in the consideration payable to the Corporation
  upon such exercise, conversion or exchange, then such Option or Convertible
  Security, as so amended or adjusted, and the Additional Shares of Common Stock
  subject thereto (determined in the manner provided in Section B.4.4.(c)(i))
  shall be deemed to have been issued effective upon such increase or decrease
  becoming effective.

                               (iv)
  Upon the expiration or termination of any unexercised Option or unconverted
  or unexchanged Convertible Security (or portion thereof) which resulted (either
  upon its original issuance or upon a revision of its terms) in an adjustment
  to the Conversion Price pursuant to the terms of Section B.4.4.(d), the Conversion
  Price shall be readjusted to such Conversion Price as would have obtained had
  such Option or Convertible Security (or portion thereof) never been issued.

                               (v)
  If the number of shares of Common Stock issuable upon the exercise, conversion
  and/or exchange of any Option or Convertible Security, or the consideration
  payable to the Corporation upon such exercise, conversion and/or exchange, is
  calculable at the time such Option or Convertible Security is issued or amended
  but is subject to adjustment based upon subsequent events, any adjustment to
  the Conversion Price provided for in this Section B.4.4.(c) shall be effected
  at the time of such issuance or amendment based on such number of shares or
  amount of consideration without regard to any provisions for subsequent adjustments
  (and any subsequent adjustments shall be treated as provided in clauses (ii)
  and (iii) of this Section B.4.4.(c)). If the number of shares of Common Stock
  issuable upon the exercise, conversion and/or exchange of any Option or Convertible
  Security, or the consideration payable to the Corporation upon such exercise,
  conversion and/or exchange, cannot be calculated at all at the time such Option
  or Convertible Security is issued or amended, any adjustment to the Conversion
  Price that would result under the terms of this Section B.4.4.(c) at the time
  of such issuance or amendment shall instead be effected at the time such number
  of shares and/or amount of consideration is first calculable (even if subject
  to subsequent adjustments), assuming for purposes of calculating such adjustment
  to the Conversion Price that such issuance or amendment took place at the time
  such calculation can first be made.

 12

                     (d)
  Adjustment of Series A Stock Conversion Prices Upon Issuance of Additional
  Shares of Common Stock. In the event the Corporation shall at any time after
  the Termination Date issue Additional Shares of Common Stock (including Additional
  Shares of Common Stock deemed to be issued pursuant to Section B.4.4.(c)), without
  consideration or for a consideration per share less than the Conversion Price
  in effect immediately prior to such issue, then the Conversion Price shall be
  reduced, concurrently with such issue, to a price (calculated to the nearest
  cent) determined in accordance with the following formula:

 CP2 = CP1*
  (A + B) ÷ (A + C).

 For purposes of the foregoing formula, the following definitions shall apply:

                       (i)
    “CP2” shall mean the Conversion Price in effect immediately
    after such issue of Additional Shares of Common Stock

                       (ii)
    “CP1” shall mean the Conversion Price in effect immediately prior
    to such issue of Additional Shares of Common Stock;

                       (iii)
    “A” shall mean the number of shares of Common Stock issued and outstanding
    immediately prior to such issue of Additional Shares of Common Stock (treating
    for this purpose as outstanding all shares of Common Stock issuable upon exercise
    of Options outstanding immediately prior to such issue or upon conversion
    or exchange of Convertible Securities (including the Series A Stock) outstanding
    (assuming exercise of any outstanding Options therefor) immediately prior
    to such issue);

                       (iv)
    “B” shall mean the number of shares of Common Stock that would have
    been issued if such Additional Shares of Common Stock had been issued at a
    price per share equal to CP1 (determined by dividing the aggregate
    consideration received by the Corporation in respect of such issue by CP1);
    and

                       (v)
    “C” shall mean the number of such Additional Shares of Common Stock
    issued in such transaction.

                     (e)
  Determination of Consideration. For purposes of this Section B.4.4.,
  the consideration received by the Corporation for the issue of any Additional
  Shares of Common Stock shall be computed as follows:

                          (i)
  Cash and Property. Such consideration shall:

                            (A)
    insofar as it consists of cash, be computed at the aggregate amount of cash
    received by the Corporation, excluding amounts paid or payable for accrued
    interest;

                            (B)
    insofar as it consists of property other than cash, be computed at the fair
    market value thereof at the time of such issue, as determined in good faith
    by the Board of Directors of the Corporation; and

 13

                            (C)
    in the event shares of Additional Common Stock are issued together with other
    shares or securities or other assets of the Corporation for consideration
    which covers both, be the proportion of such consideration so received for
    the shares of Additional Common Stock, computed as provided in clauses (A)
    and (B) above, as determined in good faith by the Board of Directors of the
    Corporation.

                          (ii)
  Options and Convertible Securities. The consideration per share received
  by the Corporation for Additional Shares of Common Stock deemed to have been
  issued pursuant to subsection B.4.4.(c), relating to Options and Convertible
  Securities, shall be determined by dividing:

                            (A)
    the total amount, if any, received or receivable by the Corporation as consideration
    for the issue of such Options or Convertible Securities, plus the minimum
    aggregate amount of additional consideration (as set forth in the instruments
    relating thereto, without regard to any provision contained therein for a
    subsequent adjustment of such consideration) payable to the Corporation upon
    the exercise of such Options or the conversion or exchange of such Convertible
    Securities, or in the case of Options for Convertible Securities, the exercise
    of such Options for Convertible Securities and the conversion or exchange
    of such Convertible Securities, by

                            (B)
    the maximum number of shares of Common Stock (as set forth in the instruments
    relating thereto, without regard to any provision contained therein for a
    subsequent adjustment of such number) issuable upon the exercise of such Options
    or the conversion or exchange of such Convertible Securities, or in the case
    of Options for Convertible Securities, the exercise of such Options for Convertible
    Securities and the conversion or exchange of such Convertible Securities.

                4.5.
  Adjustment for Stock Splits and Combinations. If the Corporation shall
  at any time or from time to time after the Termination Date effect a subdivision
  of the outstanding Common Stock, the Conversion Price in effect immediately
  before that subdivision shall be proportionately decreased so that the number
  of shares of Common Stock issuable on conversion of each share of such series
  shall be increased in proportion to such increase in the aggregate number of
  shares of Common Stock outstanding. If the Corporation shall at any time or
  from time to time after the Termination Date combine the outstanding shares
  of Common Stock, the Conversion Price in effect immediately before the combination
  shall be proportionately increased so that the number of shares of Common Stock
  issuable on conversion of each share of such series shall be decreased in proportion
  to such decrease in the aggregate number of shares of Common Stock outstanding.
  Any adjustment under this subsection shall become effective at the close of
  business on the date the subdivision or combination becomes effective.

                4.6.
  Adjustment for Certain Dividends and Distributions. In the event the
  Corporation at any time or from time to time after the Termination Date shall
  make or issue, or fix a record date for the determination of holders of Common
  Stock entitled to receive, a dividend or other distribution payable on the Common
  Stock in additional shares of Common Stock, then and in each such event the
  Conversion Price in effect immediately before such event

 14

 shall be decreased as of the time of such issuance or, in the event such a
  record date shall have been fixed, as of the close of business on such record
  date, by multiplying the Conversion Price then in effect by a fraction:

                     (i)
  the numerator of which shall be the total number of shares of Common Stock issued
  and outstanding immediately prior to the time of such issuance or the close
  of business on such record date, and

                     (ii)
  the denominator of which shall be the total number of shares of Common Stock
  issued and outstanding immediately prior to the time of such issuance or the
  close of business on such record date plus the number of shares of Common Stock
  issuable in payment of such dividend or distribution.

 Notwithstanding the foregoing, (a) if such record date shall have been fixed
  and such dividend is not fully paid or if such distribution is not fully made
  on the date fixed therefor, the Conversion Price shall be recomputed accordingly
  as of the close of business on such record date and thereafter the Conversion
  Price shall be adjusted pursuant to this subsection as of the time of actual
  payment of such dividends or distributions; and (b) that no such adjustment
  shall be made if the holders of Series A Stock simultaneously receive a dividend
  or other distribution of shares of Common Stock in a number equal to the number
  of shares of Common Stock as they would have received if all outstanding shares
  of Series A Stock had been converted into Common Stock on the date of such event.

                4.7.
  Adjustments for Other Dividends and Distributions. In the event the Corporation
  at any time or from time to time after the Termination Date shall make or issue,
  or fix a record date for the determination of holders of Common Stock entitled
  to receive, a dividend or other distribution payable in securities of the Corporation
  (other than a distribution of shares of Common Stock in respect of outstanding
  shares of Common Stock) or in other property and the provisions of Section B.1.
  do not apply to such dividend or distribution, then and in each such event the
  holders of Series A Stock shall receive, simultaneously with the distribution
  to the holders of Common Stock, a dividend or other distribution of such securities
  or other property in an amount equal to the amount of such securities or other
  property as they would have received if all outstanding shares of Series A Stock
  had been converted into Common Stock on the date of such event.

                4.8.
  Adjustment for Merger or Reorganization, etc. If there shall occur any
  reorganization, recapitalization, reclassification, consolidation or merger
  involving the Corporation in which the Common Stock (but not the Series A Stock)
  is converted into or exchanged for securities, cash or other property (other
  than a transaction covered by Sections B.2.3., B.4.4., B.4.5., B.4.6. or B.4.7.),
  then, following any such reorganization, recapitalization, reclassification,
  consolidation or merger, each share of Series A Stock shall thereafter be convertible
  in lieu of the Common Stock into which it was convertible prior to such event
  into the kind and amount of securities, cash or other property which a holder
  of the number of shares of Common Stock of the Corporation issuable upon conversion
  of one share of Series A Stock immediately prior to such reorganization, recapitalization,
  reclassification, consolidation or merger would have been entitled to receive
  pursuant to such transaction; and, in such case, appropriate adjustment (as
  determined in good faith by the Board of Directors of the

 15

 Corporation) shall be made in the application of the provisions in this Section
  B.4. with respect to the rights and interests thereafter of the holders of the
  Series A Stock, to the end that the provisions set forth in this Section B.4.
  (including provisions with respect to changes in and other adjustments of the
  Conversion Price) shall thereafter be applicable, as nearly as reasonably may
  be, in relation to any securities or other property thereafter deliverable upon
  the conversion of the Series A Stock.

                4.9.
  Certificate as to Adjustments. Upon the occurrence of each adjustment
  or readjustment of the Conversion Price pursuant to this Section B.4., the Corporation
  at its expense shall, as promptly as reasonably practicable but in any event
  not later than 20 days thereafter, compute such adjustment or readjustment in
  accordance with the terms hereof and furnish to each holder of Series A Stock
  a certificate setting forth such adjustment or readjustment (including the kind
  and amount of securities, cash or other property into which the Series A Stock
  is convertible) and showing in detail the facts upon which such adjustment or
  readjustment is based. The Corporation shall, as promptly as reasonably practicable
  after the written request at any time of any holder of Series A Stock (but in
  any event not later than 20 days thereafter), furnish or cause to be furnished
  to such holder a certificate setting forth (i) the Conversion Price then in
  effect, and (ii) the number of shares of Common Stock and the amount, if any,
  of other securities, cash or property which then would be received upon the
  conversion of Series A Stock.

                4.10.
  Notice of Record Date. In the event:

                     (a)
  the Corporation shall take a record of the holders of its Common Stock (or other
  capital stock or securities at the time issuable upon conversion of the Series
  A Stock) for the purpose of entitling or enabling them to receive any dividend
  or other distribution, or to receive any right to subscribe for or purchase
  any shares of capital stock of any class or any other securities, or to receive
  any other security; or

                     (b)
  of any capital reorganization of the Corporation or any reclassification of
  the Common Stock of the Corporation; or

                     (c)
  of any Liquidation Event or any Deemed Liquidation Event,

 then, and in each such case, the Corporation will send or cause to be sent
  to the holders of the Series A Stock a notice specifying, as the case may be,
  (i) the record date for such dividend, distribution or right, and the amount
  and character of such dividend, distribution or right, or (ii) the effective
  date on which such reorganization, reclassification, consolidation, merger,
  transfer, dissolution, liquidation or winding-up is proposed to take place,
  and the time, if any is to be fixed, as of which the holders of record of Common
  Stock (or such other capital stock or securities at the time issuable upon the
  conversion of the Series A Stock) shall be entitled to exchange their shares
  of Common Stock (or such other capital stock or securities) for securities or
  other property deliverable upon such reorganization, reclassification, consolidation,
  merger, transfer, dissolution, liquidation or winding-up, and the amount per
  share and character of such exchange applicable to the Series A Stock and the
  Common Stock. Such notice shall be sent at least 20 days prior to the record
  date or effective date for the event specified in such notice.

 16

           5. Mandatory
  Conversion.

                5.1.
  Trigger Event. Upon the closing of the sale of shares of Common Stock
  to the public at a price of at least $68.20 per share (subject to appropriate
  adjustment in the event of any stock dividend, stock split, combination or other
  similar recapitalization with respect to the Common Stock), in a firm-commitment
  underwritten public offering pursuant to an effective registration statement
  under the Securities Act of 1933, as amended, on a national securities exchange,
  resulting in at least $40 million of proceeds, net of the underwriting discount
  and commissions, to the Corporation (a “Qualified Public Offering”),
  all outstanding shares of Series A Stock shall automatically be converted into
  shares of Common Stock, at the then effective conversion rate.

                5.2.
  Procedural Requirements. All holders of record of shares of Series A
  Stock shall be sent written notice 20 days prior to the occurrence of a Qualified
  Public Offering and the place designated for mandatory conversion of all such
  shares of Series A Stock pursuant to this Section B.5. Upon receipt of such
  notice, each holder of shares of Series A Stock shall surrender his, her or
  its certificate or certificates for all such shares (or, if such holder alleges
  that such certificate has been lost, stolen or destroyed, a lost certificate
  affidavit and agreement reasonably acceptable to the Corporation to indemnify
  the Corporation against any claim that may be made against the Corporation on
  account of the alleged loss, theft or destruction of such certificate) to the
  Corporation at the place designated in such notice. If so required by the Corporation,
  certificates surrendered for conversion shall be endorsed or accompanied by
  written instrument or instruments of transfer, in form reasonably satisfactory
  to the Corporation, duly executed by the registered holder or by his, her or
  its attorney duly authorized in writing. All rights with respect to the Series
  A Stock converted pursuant to Section B.5.1., including the rights, if any,
  to receive notices and vote (other than as a holder of Common Stock), will terminate
  automatically upon the occurrence of the Qualified Public Offering (notwithstanding
  the failure of the holder or holders thereof to surrender the certificates at
  or prior to such time or the failure by the Corporation to provide the notice
  specified by this Section B.5.2.), except only the rights of the holders thereof,
  upon surrender of their certificate or certificates (or lost certificate affidavit
  and agreement) therefor, to receive the items provided for in the next sentence
  of this Section B.5.2. The date of the occurrence of a Qualified Public Offering
  shall also be a Conversion Time. As soon as practicable after a Qualified Public
  Offering and the surrender of the certificate or certificates (or lost certificate
  affidavit and agreement) for Series A Stock, the Corporation shall issue and
  deliver to such holder, or to his, her or its nominees, a certificate or certificates
  for the number of full shares of Common Stock issuable on such conversion in
  accordance with the provisions hereof, together with cash as provided in Section
  B.4.2. in lieu of any fraction of a share of Common Stock otherwise issuable
  upon such conversion and the payment of any declared but unpaid dividends that
  such holder is entitled to pursuant to Section B.1.2. Such converted Series
  A Stock shall be retired and cancelled and may not be reissued as shares of
  such series, and the Corporation may thereafter take such appropriate action
  (without the need for stockholder action) as may be necessary to reduce the
  authorized number of shares of Series A Stock accordingly.

 17

           6. Voting Rights.

                On any matter presented to the stockholders
  of the Corporation for their action or consideration at any meeting of stockholders
  of the Corporation (or by written consent of stockholders in lieu of meeting),
  each holder of outstanding shares of Series A Stock shall be entitled to cast
  the number of votes equal to the number of whole shares of Common Stock into
  which the shares of Series A Stock held by such holder are convertible as of
  the record date for determining stockholders entitled to vote on such matter.
  Except as provided by law, pursuant to Section B.7.1., or by the other provisions
  of the Certificate of Incorporation, holders of Series A Stock shall vote together
  with the holders of Common Stock as a single class.

           7. Protective
  Provisions.

                7.1.
  At any time when at least 15% of the shares of Series A Stock issued on the
  Termination Date are outstanding, the Corporation shall not, either directly
  or indirectly by amendment, merger, consolidation or otherwise, do any of the
  following without (in addition to any other vote required by law or the Certificate
  of Incorporation) the written consent or affirmative vote of the holders of
  at least 66% of the outstanding shares of Series A Stock (the “Required
  Series A Owners”), given in writing or by vote at a meeting, consenting
  or voting (as the case may be) separately as a class:

                    (a)
  amend, alter or repeal any provision of the Certificate of Incorporation or
  the Corporation’s By-Laws in a manner adverse to the rights of the holders
  of the Series A Stock;

                     (b)
  create, authorize the creation of, or issue any additional class or series of
  capital stock unless the same ranks junior to the Series A Stock with respect
  to the distribution of assets on the liquidation, dissolution or winding up
  of the Corporation, the payment of dividends and rights of redemption; or

                     (c)
  purchase or redeem (other than pursuant to equity incentive agreements with
  employees giving the Corporation the right to repurchase shares upon the termination
  of services) or pay any dividend (other than a dividend payable only in Common
  Stock or in any other stock ranking junior to the Series A Stock as to dividends)
  with respect to any shares of capital stock or any other securities that are
  junior to the Series A Stock or are convertible into or exercisable for such
  stock; provided, however, that the Corporation may redeem shares
  of Series A Stock as expressly authorized herein.

           8. Waiver.
  Any of the rights, powers, preferences and other terms of the Series A Stock
  set forth herein may be waived on behalf of all holders of Series A Stock by
  the affirmative written consent or vote of the holders of at least 66% of the
  shares of Series A Stock then outstanding.

           9. Reacquired
  Shares. Any shares of Series A Stock converted, exchanged, redeemed, purchased
  or otherwise acquired by the Corporation in any manner whatsoever shall be retired
  and canceled promptly after the acquisition thereof. All such shares of Series
  A Stock shall upon their cancellation become authorized but unissued shares
  of the Corporation’s preferred stock, par value $0.0001 per share,
  and, upon the filing of an appropriate Certificate of

 18

 Designation with the Secretary of State of the State of Delaware, may be reissued
  as part of another class or series of the Corporation’s preferred stock,
  par value $0.0001 per share.

 19

      IN WITNESS WHEREOF, the Corporation has caused
  this Amended Certificate of Designation to be executed by its duly authorized
  officer this 8th day of March, 2010.

			
	     	 EXAMWORKS, INC.
	 	 	  
	 	By: 	/s/ J. Miguel Fernandez de Castro
      

	 	Name:	 J. Miguel Fernandez de Castro
	 	Title: 	 Senior Vice President and Chief
	 	 	 Financial Officer

 20

 EXHIBIT C

  to Consent Agreement to Loan and Security Agreement

 Shareholders Agreement Amendment

 (see attached)

 SECOND AMENDMENT TO STOCKHOLDERS’ AGREEMENT

      THIS SECOND AMENDMENT TO THE STOCKHOLDERS’
  AGREEMENT (this “Amendment”) is made and entered into as
  of March 12, 2010 and effective as of the Effective Date (as defined below)
  by and among ExamWorks, Inc., a Delaware corporation (the “Company”),
  ExamWorks Holdings, LLLP, a Georgia limited liability limited partnership (“Holdings”),
  Richard E. Perlman and James K. Price. Capitalized terms used but not defined
  herein shall have the meanings given to them in the Stockholders’ Agreement
  dated as of July 14, 2008, as amended on December 4, 2009 (the “Stockholders’
  Agreement”), by and among Holdings, the Company, and the stockholders
  party thereto (together with Holdings, the “Stockholders”).

 RECITALS

      WHEREAS, in accordance with the provisions of
  the Company’s Amended and Restated Certificate of Incorporation, the Board
  of Directors of the Company, (the “Board of Directors”) has
  adopted resolutions creating a series of preferred stock, par value $0.0001
  per share, designated as “Series A Convertible Preferred Stock” (the
  “Series A Preferred Stock”);

      WHEREAS, pursuant to that certain Confidential
  Private Placement Memorandum, dated February 22, 2010 as supplemented by the
  First Supplement, dated March 10, 2010, the Company is conducting a private
  placement of the Series A Preferred Stock (the “Offering”);

      WHEREAS, in connection with, and effective upon
  the initial closing of the Offering (the “Effective Date”),
  the Company desires to amend the Stockholders’ Agreement and to provide
  that the Series A Preferred Stock issued pursuant to the Offering shall be deemed
  “Stock” under the Stockholders’ Agreement; and

      WHEREAS, upon the Effective Date, each holder
  of the Series A Preferred Stock shall become a party to this Amendment.

      NOW, THEREFORE, pursuant to Section 11(a) of
  the Stockholders’ Agreement, the Stockholders’ Agreement is hereby
  amended as follows:

 1. Amendment to Recitals. Recital A of the Stockholders’
  Agreement is hereby amended and restated in its entirety to provide as follows:

      “A. The Stockholders currently own
  the number of shares of the Company’s presently issued and outstanding
  shares of common stock (the “Common Stock”) and/or Series A
  Preferred Stock (the “Series A Preferred Stock,” and collectively
  with the Common Stock, the “Stock”) as set forth on Schedule
  I. (For all purposes of this Agreement, when calculating the number
  of shares of Stock held by a Stockholder, or any other calculation based thereon,
  all shares of Series A Preferred Stock shall be deemed to have been converted
  into Common Stock at the conversion ratio then in effect, in accordance with
  the terms of the Certificate of

 Designation with respect to the Series A Preferred Stock (the “Certificate
  of Designation”)); and”

 2. Amendment and Restatement of Section 4(a). The first paragraph
  of Section 4(a) of the Stockholders’ Agreement is hereby amended and restated
  in its entirety to provide as follows (and Section 4(a) shall otherwise remain
  unchanged and in full force and effect):

      ARTICLE II    “(a) Come-Along Rights.
  In the event that Holdings receives an offer to purchase shares of Stock held
  by Holdings, and the offeror, as a condition to such purchase, requires or commits
  to purchase, or to cause the Company to redeem, all (but not less than all)
  of the other shares of Stock on the same per share price and terms as the offer
  for the shares of Stock held by Holdings, each other Stockholder (and any Permitted
  Transferee of the shares of Stock) shall be obligated, at the election of Holdings,
  to sell to the offeror or to the Company, as the case may be, that number of
  shares of Stock equal to the sum of (x) the number of shares actually held by
  such other Stockholder multiplied by (y) a fraction, the numerator of
  which is the number of shares of Stock proposed to be transferred by Holdings,
  and the denominator of which is the total number of shares of Stock held by
  Holdings, at the same per share price and on the same terms and conditions offered
  to Holdings for the shares of Stock held by Holdings. Notwithstanding the foregoing,
  holders of the Series A Preferred Stock shall not be obligated to sell to the
  offeror or to the Company, as the case may be, any shares of Series A Preferred
  Stock, unless the consideration received shall be at least equal to the Series
  A Liquidation Amount, as defined in the Certificate of Designation. For the
  avoidance of doubt, if the offeror has not specified a proposed purchase price
  for shares of Series A Preferred Stock, the proposed purchase price for each
  share of Series A Preferred Stock shall be determined based on the conversion
  ratio of the Series A Preferred Stock then in effect as if such shares of Series
  A Preferred Stock had been converted to Common Stock in accordance with the
  terms of the Certificate of Designation. Within ten (10) days after the date
  of the written notice of Holdings’ election made pursuant to this Section
  4(a), the other Stockholders (and any Permitted Transferee of the shares
  of Stock) shall deliver the certificate(s) representing shares of Stock to Holdings
  endorsed in blank. Notwithstanding the foregoing, the other Stockholders and
  any Permitted Transferee of the shares of Stock (collectively, the “Seller”)
  will not be required to comply with this Section 4(a) in connection with
  any specific transaction (the “Proposed Sale”) unless:”

 3. Amendment and Restatement of Section 4(b). Section 4(b) of
  the Stockholders’ Agreement is hereby amended and restated in its entirety
  to provide as follows:

           “(b) Co-Sale
  Rights. In the event Holdings proposes to sell any shares of the Stock held
  by Holdings to any person (except to the Company by way of redemption, repurchase
  or the like), the other Stockholders shall then have a right of co-sale (the
  “Right of Co-Sale”) with respect to any shares of Stock proposed to
  be sold. Before any proposed transfer, Holdings shall give the other Stockholders
  ten (10) days written notice (the “Co-Sale Notice”) which sets
  forth the terms of the proposed sale of the shares of Stock held by Holdings,
  including, without limitation, the proposed purchase price for shares of Series
  A Preferred Stock, which, in the event Holdings is not proposing to sell any
  shares of the Series A Preferred Stock, shall be determined based on the conversion
  ratio of the Series A Preferred Stock then in effect

 as if such shares of Series A Preferred Stock had been converted to Common
  Stock in accordance with the terms of the Certificate of Designation. Each other
  Stockholder shall have the right at any time within ten (10) days from the date
  of the Co-Sale Notice within which to deliver to Holdings and to the Company
  notice of its election (the “Election Notice”) to exercise
  the Right of Co-Sale and to sell to the proposed transferee named in the Co-Sale
  Notice (at the applicable price per share set forth in the Co-Sale Notice) the
  aggregate number of shares of Stock proposed to be sold to such purchaser multiplied
  by a fraction, the numerator of which is the number of shares actually held
  by such other Stockholder and the denominator of which equals the total number
  of shares of Stock held by all of the Stockholders of the Company. After the
  delivery of the Election Notice, the Stockholders shall have the right to sell
  their respective portion of the shares of Stock to the proposed transferee,
  and Holdings shall have the right to sell its portion of shares of Stock remaining
  after the exercise, if any, by the other Stockholders of their Right of Co-Sale,
  on the same terms and conditions otherwise described in the Co-Sale Notice.
  Any Stockholder who exercises his, her or its Right of Co-Sale under this Section
  4(b) shall be bound by the same terms and conditions as are both agreed
  to by Holdings in the applicable sale agreement (including any indemnity and
  escrow provisions thereof) and consistent with the Co-Sale Notice; provided,
  however, in no event shall any such Stockholder be required to represent
  to the prospective transferee to more than such Stockholder’s valid title
  to (and absence of any encumbrances or liens upon) the Stock and such Stockholder’s
  authority to enter into such sale agreement and related documents, as well as
  the validity, binding nature and enforceability of such agreements against such
  Stockholder. Such sale shall be consummated not later than sixty (60) days following
  the Election Notice. Any proposed transfer on terms and conditions differing
  materially from those described in the Election Notice, shall again be subject
  to the Right of Co-Sale and shall require compliance by Holdings with the procedures
  described in this Section 4.”

 4. Effective Time. The amendments set forth herein shall be
  effective as of the Effective Date, as if made on and as of the Effective Date.

 5. No Other Amendments. Except as expressly modified or amended
  by this Amendment, all terms and conditions set forth in the Stockholders’
  Agreement shall remain in full force and effect and such Stockholders’
  Agreement, as amended hereby, is hereby ratified in all respects.

 6. Reaffirmation. The parties hereby confirm and ratify each
  of the provisions of the Stockholders’ Agreement as amended hereby.

 7. Full Force and Effect; Counterparts. The Stockholders’
  Agreement shall remain in full force and effect in accordance with its terms
  and provisions except as amended by this Amendment. This Amendment shall be
  binding on the parties and their respective successors and assigns. This Amendment
  may be executed in one or more counterparts, all counterparts shall be valid
  and binding on the party executing them and all counterparts shall together
  constitute one and the same document for all purposes. This Amendment may be
  executed and delivered by facsimile signature for execution on the part of one
  or more parties hereto.

 [Signature page follows]

      IN WITNESS WHEREOF, the parties hereto
  have executed this Amendment as of the date first set above.

	
	 COMPANY:
	 
	 EXAMWORKS, INC.
	  
	 

      Name: Richard E. Perlman
	 Title: Co-Chairman
	 
	 STOCKHOLDERS:
	 
	 EXAMWORKS HOLDINGS, LLLP
	 
	 By: Compass Partners, L.L.C., its General
	 Partner
	  
	 

      Name: Richard E. Perlman
	 Title: President
	  
	 

      Name: Richard E. Perlman
	  
	 

      Name: James K. Price

 EXHIBIT D

  to Consent Agreement to Loan and Security Agreement

 Investor Rights Agreement

 (see attached)

 INVESTOR RIGHTS AGREEMENT

 BY AND AMONG

 EXAMWORKS, INC.

 AND

 THE INVESTORS PARTY HERETO

 DATED AS OF MAY 7, 2010

 INVESTOR RIGHTS AGREEMENT

      THIS INVESTOR RIGHTS AGREEMENT (this “Agreement”)
  is made as of May 7, 2010, by and among ExamWorks, Inc., a Delaware corporation
  (the “Company”) and each of the investors listed on Schedule
  A hereto, each of which is referred to in this Agreement as an “Investor,”
  and any additional investor that becomes a party to this Agreement in accordance
  with Section 4.9 hereof.

 RECITALS

           WHEREAS, the
  Company is conducting an offering (the “Offering”) of up to
  967,741 shares of its Series A Preferred Stock (as defined below) at $34.10
  per share (the “Original Purchase Price);

           WHEREAS,
  the Company and each Investor have entered into a subscription agreement (the
  “Subscription Agreement”) in connection with the issuance and
  purchase of Series A Preferred Stock; and

           WHEREAS,
  in order to induce the Company to enter into the Subscription Agreements and
  to induce the Investors to invest funds in the Company pursuant to the Subscription
  Agreements, the Investors and the Company hereby agree that this Agreement shall
  govern the rights of the Investors to cause the Company to register shares of
  Common Stock (as defined below) issuable upon conversion of the Series A Preferred
  Stock, to receive certain information from the Company, and shall govern certain
  other matters as set forth in this Agreement;

           NOW, THEREFORE,
  the parties hereby agree as follows:

      1. Definitions. For purposes of this
  Agreement:

           1.1 “Affiliate”
  means, with respect to any specified Person, any other Person who, directly
  or indirectly, controls, is controlled by, or is under common control with such
  Person, including without limitation any general partner, managing member, officer
  or director of such Person or any venture capital fund now or hereafter existing
  that is controlled by one or more general partners or managing members of, or
  shares the same management company with, such Person.

           1.2 “Agreement”
  shall have the meaning given to such term in the introductory paragraph hereof.

           1.3 “Common
  Stock” means shares of the Company’s common stock, par value $0.0001
  per share.

           1.4 “Company”
  has the meaning given to such term in the introductory paragraph hereof.

           1.5 “Completion
  Date” means the date that is the 24-month anniversary of the final
  closing date of the Offering.

 1

           1.6 “Damages”
  means any loss, damage, or liability (joint or several) to which a party hereto
  may become subject under the Securities Act, the Exchange Act, or other federal
  or state law, insofar as such loss, damage, or liability (or any action in respect
  thereof) arises out of or is based upon (i) any untrue statement or alleged
  untrue statement of a material fact contained in any registration statement
  of the Company, including any preliminary prospectus or final prospectus contained
  therein or any amendments or supplements thereto, or any issuer free writing
  prospectus or any “issuer information” filed or to be filed pursuant
  to Rule 433(d) under the Securities Act; (ii) an omission or alleged omission
  to state therein a material fact required to be stated therein, or necessary
  to make the statements therein not misleading; or (iii) any violation or alleged
  violation by the indemnifying party (or any of its agents or Affiliates) of
  the Securities Act, the Exchange Act, any state securities law, or any rule
  or regulation promulgated under the Securities Act, the Exchange Act, or any
  state securities law.

           1.7 “Exchange
  Act” means the Securities Exchange Act of 1934, as amended, and the
  rules and regulations promulgated thereunder.

           1.8 “Excluded
  Registration” means (i) a registration relating to the sale of securities
  to employees of the Company or a subsidiary pursuant to a stock option, stock
  purchase, or similar plan or (ii) a registration relating to an SEC Rule 145
  transaction.

           1.9 “Filing
  Date” means the date that is the 18-month anniversary of the final
  closing date of the Offering.

           1.10 “FINRA”
  means the Financial Industry Regulation Authority, Inc.

           1.11 “Form
  S-1” means such form under the Securities Act or any successor registration
  form under the Securities Act subsequently adopted by the SEC.

           1.12 “GAAP”
  means generally accepted accounting principles in the United States.

           1.13 “Holder”
  means any holder of Registrable Securities who is a party to this Agreement,
  including pursuant to Section 4.9 hereto.

           1.14 “Immediate
  Family Member” means a child, stepchild, grandchild, parent, stepparent,
  grandparent, spouse, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law,
  brother-in-law, or sister-in-law, including adoptive relationships, of a natural
  person referred to herein, or anyone residing in such person’s home.

           1.15 “IPO”
  means the Company’s first underwritten public offering of its Common Stock
  under the Securities Act.

           1.16 “IPO
  Registration Statement” shall have the meaning given to such term in
  Section 2.1(a) hereto.

           1.17 “Liquidated
  Damages” shall have the meaning given to such term in Section 2.1(a) hereto.

 2

           1.18 “Major
  Investor” means any Investor that, individually or together with such
  Investor’s Affiliates, holds at least 146,628 shares of Series A Preferred
  Stock.

           1.19 “Offering”
  shall have the meaning given to such term in the Recitals hereto.

           1.20 “Original
  Purchase Price” shall have the meaning given to such term in the Recitals
  hereto.

           1.21 “Other
  Selling Holders” shall have the meaning given to such term in Section
  2.1(b) hereof.

           1.22 “Person”
  means any individual, corporation, partnership, trust, limited liability company,
  association or other entity.

           1.23 “Registrable
  Securities” means (i) the Common Stock issuable or issued upon conversion
  of the Series A Preferred Stock and (ii) any Common Stock issued as (or issuable
  upon the conversion or exercise of any warrant, right, or other security that
  is issued as) a dividend or other distribution with respect to, or in exchange
  for or in replacement of, the shares referenced in clause (i) above; excluding
  in all cases, however, any Registrable Securities sold by a Person in a transaction
  in which the applicable rights under this Agreement are not assigned pursuant
  to Section 4.1 and excluding for purposes of Section 2, any shares
  for which registration rights have terminated pursuant to Section 2.11 of
  this Agreement.

           1.24 “Registrable
  Securities then outstanding” means the number of shares determined
  by adding the number of shares of outstanding Common Stock that are Registrable
  Securities and the number of shares of Common Stock issuable (directly or indirectly)
  pursuant to then exercisable and/or convertible securities that are Registrable
  Securities.

           1.25 “Restricted
  Securities” means the securities of the Company required to bear the
  legend set forth in Section 2.10(b) hereof.

           1.26 “SEC”
  means the Securities and Exchange Commission.

           1.27 “SEC
  Rule 144” means Rule 144 promulgated by the SEC under the Securities
  Act.

           1.28 “SEC
  Rule 145” means Rule 145 promulgated by the SEC under the Securities
  Act.

           1.29 “Securities
  Act” means the Securities Act of 1933, as amended, and the rules and
  regulations promulgated thereunder.

           1.30 “Selling
  Expenses” means all underwriting discounts, selling commissions, and
  stock transfer taxes applicable to the sale of Registrable Securities, and fees
  and disbursements of counsel for any Holder, except for the fees and disbursements
  of the Selling Holder Counsel borne and paid by the Company as provided in Section
  2.5.

 3

           1.31 “Selling
  Holder” shall have the meaning given to such term in Section 2.1(b) hereof.

           1.32 “Selling
  Holder Counsel” shall have the meaning given to such term in Section
  2.5 hereof.

           1.33 “Series
  A Preferred Stock” means shares of the Company’s Series A Preferred
  Stock, par value $0.0001 per share.

           1.34 “Subscription
  Agreement” shall have the meaning given to such term in the Recitals
  hereto.

      2. Registration Rights.

           2.1 Registration
  Rights with Respect to IPO.

                     IPO
  Registration Statement. Subject to Section 2.1(c), the Company shall
  (i) prepare and file with the SEC a Form S-1 registration statement under the
  Securities Act (the “IPO Registration Statement”) with respect
  to its IPO no later than the Filing Date and (ii) use commercially reasonable
  efforts to consummate the IPO as promptly as practicable, but in no event later
  than the Completion Date.

                          The
  Company acknowledges and agrees that the Holders of Registrable Securities will
  suffer damages if the Company fails to fulfill its material obligations under
  Section 2.1(a) hereof and that it would not be feasible to ascertain
  the extent of such damages with precision. Accordingly, the Company agrees to
  pay liquidated damages for each month (or any pro-rata portion of any month)
  on the Series A Preferred Stock held by Investors (over and above any dividends
  accruing or payable with respect thereto) equal to two percent (2%) of the Original
  Purchase Price, payable in arrears at the end of the month (or any pro rata
  portion thereof) (“Liquidated Damages”) if (i) the IPO Registration
  Statement has not been filed on or prior to the Filing Date or (ii) the IPO
  has not been consummated on or prior to the Completion Date, provided, however,
  that Liquidated Damages shall only be payable with respect to the period from
  the Filing Date or the Completion Date, as applicable, that the IPO Registration
  Statement has not been filed or the IPO has not been consummated, as applicable,
  and, provided further, that Liquidated Damages will not accrue under
  more than one of the foregoing clauses (i) or (ii) at any one
  time.

                     Inclusion
  of Registrable Securities in IPO. The Company shall notify each Holder of
  Registrable Securities in writing at least 20 days prior to filing the IPO Registration
  Statement of its rights to include Registrable Securities in the IPO Registration
  Statement, if any, pursuant to this Section 2.1. If Holders of Registrable
  Securities have the right to include Registrable Securities in the IPO Registration
  Statement, a Holder desiring to include all or any portion of its Registrable
  Securities (a “Selling Holder”) shall notify the Company in
  writing no later than five (5) days after the date of receipt of the Company’s
  notice, such notice to include the number of Registrable Securities such Selling
  Holder wishes to include in the IPO Registration Statement. Subject to Section
  2.3 below, if and to the extent other existing stockholders of Common Stock
  (“Other Selling Holders”) will be registering Common Stock
  in the IPO Registration Statement, the Company shall use its best efforts to
  include in the IPO Registration Statement, such number of shares of Registrable
  Securities held by Selling Holders

 4

 as is proportionate to the number of shares of Common Stock held by Other
  Selling Holders which are to be included in the IPO Registration Statement.

                     Deferral.
  Notwithstanding the foregoing, if the Company shall furnish to Selling Holders,
  a certificate signed by the Chief Executive Officer of the Company stating that,
  in the good faith judgment of the Board of Directors of the Company, it would
  be seriously detrimental to the Company and its stockholders for the IPO Registration
  Statement to be filed or for the Company to consummate the IPO, and it is therefore
  essential to defer the filing of IPO Registration Statement and/or the closing
  of the IPO, then the Company shall have the right, without incurring the obligation
  to pay Liquidated Damages as set forth in Section 2.1(a) above, to defer
  such filing or closing for a period of not more than ninety (90) days following
  the Filing Date or Closing Date, as applicable; provided, however, that
  the Company may not utilize this right more than once.

                     Subordination/Exhibit
  A hereto. The Company and each Investor and Holder of Registrable Securities
  hereby agrees that Exhibit A attached hereto is hereby incorporated into
  this Agreement by this reference thereto and each unconditionally and irrevocably
  agrees to be legally bound by the terms, conditions and provisions contained
  in Exhibit A. Each reference in this Agreement to “this Agreement,”
  “hereunder,” “hereof,” “herein,” or words of like
  import shall mean and be a reference to this Agreement together with Exhibit
  A.

                2.2
  Company Registration. If the Company proposes to register (including,
  for this purpose, a registration effected by the Company for stockholders other
  than the Holders) any of its Common Stock under the Securities Act in connection
  with the public offering of such securities solely for cash (other than in the
  IPO or an Excluded Registration), the Company shall, at such time, promptly
  give each Holder notice of such registration. Upon the request of each Holder
  given within five (5) days after such notice is given by the Company, the Company
  shall, subject to the provisions of Section 2.3, cause to be registered
  all of the Registrable Securities that each such Holder has requested to be
  included in such registration. The Company shall have the right to terminate
  or withdraw any registration initiated by it under this Section 2.2 before
  the effective date of such registration, whether or not any Holder has elected
  to include Registrable Securities in such registration. The expenses (other
  than Selling Expenses) of such withdrawn registration shall be borne by the
  Company in accordance with Section 2.5.

                2.3
  Underwriting Requirements. In connection with the IPO pursuant to Section
  2.1 and any offering involving an underwriting of shares of the Company’s
  capital stock pursuant to Section 2.2, the Company shall not be required
  to include any of the Holders’ Registrable Securities in such underwriting
  unless the Holders accept the terms of the underwriting as agreed upon between
  the Company and its underwriters, and then only in such quantity as the underwriters
  in their sole discretion determine will not jeopardize the success of the offering
  by the Company. If the total number of securities, including Registrable Securities,
  requested by stockholders to be included in such offering exceeds the number
  of securities to be sold (other than by the Company) that the underwriters in
  their reasonable discretion determine is compatible with the success of the
  offering, then the Company shall be required to include in the offering only
  that number of such securities, including Registrable Securities, which the
  underwriters and the Company in their sole discretion determine will not jeopardize
  the success of the offering. If the underwriters determine that less than all
  of the Registrable Securities

 5

 requested to be registered can be included in such offering, then the Registrable
  Securities that are included in such offering shall be allocated among the Selling
  Holders in proportion (as nearly as practicable) to the number of Registrable
  Securities owned by each Selling Holder or in such other proportions as shall
  mutually be agreed to by all such Selling Holders. To facilitate the allocation
  of shares in accordance with the above provisions, the Company or the underwriters
  may round the number of shares allocated to any Holder to the nearest 100 shares.
  For purposes of the provision in this Section 2.3 concerning apportionment,
  for any Selling Holder that is a partnership, limited liability company, or
  corporation, the partners, members, retired partners, retired members, stockholders,
  and Affiliates of such Holder, or the estates and Immediate Family Members of
  any such partners, retired partners, members, and retired members and any trusts
  for the benefit of any of the foregoing Persons, shall be deemed to be a single
  Selling Holder, and any pro rata reduction with respect to such Selling Holder
  shall be based upon the aggregate number of Registrable Securities owned by
  all Persons included in such Selling Holder, as defined in this sentence.

                2.4
  Furnish Information. It shall be a condition precedent to the obligations
  of the Company to take any action pursuant to this Section 2 with respect
  to the Registrable Securities of any Selling Holder that such Holder shall furnish
  to the Company such information regarding itself, the Registrable Securities
  held by it, and the intended method of disposition of such securities as is
  reasonably required to effect the registration of such Holder’s Registrable
  Securities.

                2.5
  Expenses of Registration. All expenses (other than Selling Expenses)
  incurred in connection with registrations, filings, or qualifications pursuant
  to Section 2, including all registration, filing, and qualification fees;
  printers’ and accounting fees; fees and disbursements of counsel for the
  Company; and the reasonable fees and disbursements of one counsel for the Selling
  Holders (“Selling Holder Counsel”), shall be borne and paid
  by the Company.

                2.6
  Delay of Registration. No Holder shall have any right to obtain or seek
  an injunction restraining or otherwise delaying any registration pursuant to
  this Agreement as the result of any controversy that might arise with respect
  to the interpretation or implementation of this Section 2.

                2.7
  Indemnification. If any Registrable Securities are included in a registration
  statement under this Section 2:

                     (a)
  To the extent permitted by law, the Company will indemnify and hold harmless
  each Selling Holder, and the partners, members, officers, directors, and stockholders
  of each such Holder; legal counsel and accountants for each such Holder; any
  underwriter (as defined in the Securities Act) for each such Holder; and each
  Person, if any, who controls such Holder or underwriter within the meaning of
  the Securities Act or the Exchange Act, against any Damages, and the Company
  will pay to each such Holder, underwriter, controlling Person, or other aforementioned
  Person any legal or other expenses reasonably incurred thereby in connection
  with investigating or defending any claim or proceeding from which Damages may
  result, as such expenses are incurred; provided, however, that the indemnity
  agreement contained in this Section 2.7(a) shall not apply to amounts
  paid in settlement of any such claim or proceeding if such settlement is effected
  without the consent of the Company,

 6

 which consent shall not be unreasonably withheld, nor shall the Company be
  liable for any Damages to the extent that they arise out of or are based upon
  actions or omissions made in reliance upon and in conformity with written information
  furnished by or on behalf of any such Holder, underwriter, controlling Person,
  or other aforementioned Person expressly for use in connection with such registration.

                     (b)
  To the extent permitted by law, each Selling Holder, severally and not jointly,
  will indemnify and hold harmless the Company, and each of its directors, each
  of its officers who has signed the registration statement, each Person (if any),
  who controls the Company within the meaning of the Securities Act, legal counsel
  and accountants for the Company, any underwriter (as defined in the Securities
  Act), any other Holder selling securities in such registration statement, and
  any controlling Person of any such underwriter or other Holder, against any
  Damages, in each case only to the extent that such Damages arise out of or are
  based upon actions or omissions made in reliance upon and in conformity with
  written information furnished by or on behalf of such Selling Holder expressly
  for use in connection with such registration; and each such Selling Holder will
  pay to the Company and each other aforementioned Person any legal or other expenses
  reasonably incurred thereby in connection with investigating or defending any
  claim or proceeding from which Damages may result, as such expenses are incurred;
  provided, however, that the indemnity agreement contained in this Section
  2.7(b) shall not apply to amounts paid in settlement of any such claim or
  proceeding if such settlement is effected without the consent of the Holder,
  which consent shall not be unreasonably withheld; and provided further that
  in no event shall the aggregate amounts payable by any Holder by way of indemnity
  or contribution under this Sections 2.7(b) and 2.7(d) exceed the
  proceeds from the offering received by such Holder (net of any Selling Expenses
  paid by such Holder), except in the case of fraud or willful misconduct by such
  Holder.

                     (c)
  Promptly after receipt by an indemnified party under this Section 2.7 of
  notice of the commencement of any action (including any governmental action)
  for which a party may be entitled to indemnification hereunder, such indemnified
  party will, if a claim in respect thereof is to be made against any indemnifying
  party under this Section 2.7, give the indemnifying party notice of the
  commencement thereof. The indemnifying party shall have the right to participate
  in such action and, to the extent the indemnifying party so desires, participate
  jointly with any other indemnifying party to which notice has been given, and
  to assume the defense thereof with counsel mutually satisfactory to the parties;
  provided, however, that an indemnified party (together with all other
  indemnified parties that may be represented without conflict by one counsel)
  shall have the right to retain one separate counsel, with the fees and expenses
  to be paid by the indemnifying party, if representation of such indemnified
  party by the counsel retained by the indemnifying party would be inappropriate
  due to actual or potential differing interests between such indemnified party
  and any other party represented by such counsel in such action. The failure
  to give notice to the indemnifying party within a reasonable time of the commencement
  of any such action shall relieve such indemnifying party of any liability to
  the indemnified party under this Section 2.7, to the extent that such
  failure materially prejudices the indemnifying party’s ability to defend
  such action. The failure to give notice to the indemnifying party will not relieve
  it of any liability that it may have to any indemnified party otherwise than
  under this Section 2.7.

                (d)
  To provide for just and equitable contribution to joint liability under the
  Securities Act in any case in which either (i) any party otherwise entitled
  to

 7

 indemnification hereunder makes a claim for indemnification pursuant to this
  Section 2.7 but it is judicially determined (by the entry of a final
  judgment or decree by a court of competent jurisdiction and the expiration of
  time to appeal or the denial of the last right of appeal) that such indemnification
  may not be enforced in such case, notwithstanding the fact that this Section
  2.7 provides for indemnification in such case, or (ii) contribution under
  the Securities Act may be required on the part of any party hereto for which
  indemnification is provided under this Section 2.7, then, and in each
  such case, such parties will contribute to the aggregate losses, claims, damages,
  liabilities, or expenses to which they may be subject (after contribution from
  others) in such proportion as is appropriate to reflect the relative fault of
  each of the indemnifying party and the indemnified party in connection with
  the statements, omissions, or other actions that resulted in such loss, claim,
  damage, liability, or expense, as well as to reflect any other relevant equitable
  considerations. The relative fault of the indemnifying party and of the indemnified
  party shall be determined by reference to, among other things, whether the untrue
  or allegedly untrue statement of a material fact, or the omission or alleged
  omission of a material fact, relates to information supplied by the indemnifying
  party or by the indemnified party and the parties’ relative intent, knowledge,
  access to information, and opportunity to correct or prevent such statement
  or omission; provided, however, that, in any such case, (x) no Holder
  will be required to contribute any amount in excess of the public offering price
  of all such Registrable Securities offered and sold by such Holder pursuant
  to such registration statement, and (y) no Person guilty of fraudulent misrepresentation
  (within the meaning of Section 11(f) of the Securities Act) will be entitled
  to contribution from any Person who was not guilty of such fraudulent misrepresentation;
  and provided further that in no event shall a Holder’s liability
  pursuant to this Section 2.7(d), when combined with the amounts paid
  or payable by such Holder pursuant to Section 2.7(b), exceed the proceeds
  from the offering received by such Holder (net of any Selling Expenses paid
  by such Holder), except in the case of willful misconduct or fraud by such Holder.

                     (e)
  Notwithstanding the foregoing, to the extent that the provisions on indemnification
  and contribution contained in the underwriting agreement entered into in connection
  with the underwritten public offering are in conflict with the foregoing provisions,
  the provisions in the underwriting agreement shall control.

                     (f)
  Unless otherwise superseded by an underwriting agreement entered into in connection
  with the underwritten public offering, the obligations of the Company and Holders
  under this Section 2.7 shall survive the completion of any offering of
  Registrable Securities in a registration under this Section 2, and otherwise
  shall survive the termination of this Agreement.

                2.8
  Rule 144. With a view to making available to the Holders the benefits
  of Rule 144 under the Securities Act and any other rule or regulation of the
  SEC that may permit a Holder to sell securities of the Company to the public
  without registration, to the extent the Series A Preferred Stock constituted
  “restricted securities,” as such term is defined in Rule 144, the
  Company shall make and keep available adequate current public information, as
  those terms are understood and defined in Rule 144.

                2.9
  Lock-up Agreement. Each Holder hereby agrees that it will not, without
  the prior written consent of the managing underwriter, during the period commencing
  on the date of the final prospectus relating to the IPO and ending on the date
  specified by the Company and

 8

 the managing underwriter (such period not to exceed one hundred eighty (180)
  days, which period may be extended upon the request of the managing underwriter,
  to the extent required by any FINRA rules, for an additional period of up to
  fifteen (15) days if the Company issues or proposes to issue an earnings or
  other public release within fifteen (15) days of the expiration of the 180-day
  lockup period, (i) lend; offer; pledge; sell; contract to sell; sell any option
  or contract to purchase; purchase any option or contract to sell; grant any
  option, right, or warrant to purchase; or otherwise transfer or dispose of,
  directly or indirectly, any shares of Common Stock or any securities convertible
  into or exercisable or exchangeable (directly or indirectly) for Common Stock
  held immediately before the effective date of the IPO Registration Statement
  or (ii) enter into any swap or other arrangement that transfers to another,
  in whole or in part, any of the economic consequences of ownership of such securities,
  whether any such transaction described in clause (i) or (ii) above is to be
  settled by delivery of Common Stock or other securities, in cash, or otherwise.
  The foregoing provisions of this Section 2.9 shall apply only to the
  IPO, shall not apply to the sale of any shares to an underwriter pursuant to
  an underwriting agreement, and shall be applicable to the Holders only if all
  officers and directors are subject to the same restrictions and the Company
  uses commercially reasonable efforts to obtain a similar agreement from all
  stockholders individually owning more than five percent (5%) of the Company’s
  outstanding Common Stock (after giving effect to conversion into Common Stock
  of all outstanding Series A Preferred Stock). The underwriters in connection
  with the IPO are intended third-party beneficiaries of this Section 2.9 and
  shall have the right, power, and authority to enforce the provisions hereof
  as though they were a party hereto. Each Holder further agrees to execute such
  agreements as may be reasonably requested by the underwriters in connection
  with such IPO that are consistent with this Section 2.9 or that are necessary
  to give further effect thereto. Any discretionary waiver or termination of the
  restrictions of any or all of such agreements by the Company or the underwriters
  shall apply pro rata to all Holders subject to such agreements, based on the
  number of shares subject to such agreements.

           2.10 Restrictions
  on Transfer.

                     (a)
  The Series A Preferred Stock and the Registrable Securities shall not be sold,
  pledged, or otherwise transferred, and the Company shall not recognize and shall
  issue stop-transfer instructions to its transfer agent with respect to any such
  sale, pledge, or transfer, except upon the conditions specified in this Agreement,
  which conditions are intended to ensure compliance with the provisions of the
  Securities Act. A transferring Holder will cause any proposed purchaser, pledgee,
  or transferee of the Series A Preferred Stock and the Registrable Securities
  held by such Holder to agree to take and hold such securities subject to the
  provisions and upon the conditions specified in this Agreement.

                     (b)
  Each certificate or instrument representing (i) the Series A Preferred Stock,
  (ii) the Registrable Securities, and (iii) any other securities issued in respect
  of the securities referenced in clauses (i) and (ii) upon any stock split, stock
  dividend, recapitalization, merger, consolidation, or similar event, shall (unless
  otherwise permitted by the provisions of Section 2.10(c)) be stamped
  or otherwise imprinted with a legend substantially in the following form:

   “THE SHARES REPRESENTED HEREBY HAVE BEEN ACQUIRED FOR INVESTMENT PURPOSES
    ONLY AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES

 9

   ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER ANY APPLICABLE STATE
    SECURITIES LAWS. THE SHARES REPRESENTED HEREBY MAY NOT BE SOLD OR TRANSFERRED
    IN THE ABSENCE OF REGISTRATION OR AN EXEMPTION THEREFROM UNDER SUCH ACT AND
    UNDER ANY APPLICABLE STATE SECURITIES LAWS. EXAMWORKS, INC. (THE "COMPANY"),
    IN ITS SOLE DISCRETION, SHALL HAVE THE RIGHT TO REQUIRE AN OPINION OF COUNSEL
    REASONABLY SATISFACTORY TO THE COMPANY TO THE EFFECT THAT REGISTRATION UNDER
    THE ACT IS NOT REQUIRED IN CONNECTION WITH ANY PROPOSED TRANSFER NOR IS SUCH
    TRANSFER IN VIOLATION OF ANY APPLICABLE STATE SECURITIES LAWS. THIS LEGEND
    SHALL BE ENDORSED UPON ANY CERTIFICATE ISSUED IN EXCHANGE FOR THIS CERTIFICATE.”
    

  THE SECURITIES REPRESENTED HEREBY MAY BE TRANSFERRED ONLY IN ACCORDANCE WITH
    THE TERMS OF AN AGREEMENT BETWEEN THE COMPANY AND THE STOCKHOLDER, A COPY
    OF WHICH IS ON FILE WITH THE SECRETARY OF THE COMPANY.

           The Holders consent
  to the Company making a notation in its records and giving instructions to any
  transfer agent of the Restricted Securities in order to implement the restrictions
  on transfer set forth in this Section 2.10.

                     (c)
  The holder of each certificate representing Restricted Securities, by acceptance
  thereof, agrees to comply in all respects with the provisions of this Section
  2.10. Before any proposed sale, pledge, or transfer of any Restricted Securities,
  unless there is in effect a registration statement under the Securities Act
  covering the proposed transaction, the Holder thereof shall give notice to the
  Company of such Holder’s intention to effect such sale, pledge, or transfer.
  Each such notice shall describe the manner and circumstances of the proposed
  sale, pledge, or transfer in sufficient detail and, if reasonably requested
  by the Company, shall be accompanied at such Holder’s expense by either
  (i) a written opinion of legal counsel who shall, and whose legal opinion shall,
  be reasonably satisfactory to the Company, addressed to the Company, to the
  effect that the proposed transaction may be effected without registration under
  the Securities Act; (ii) a “no action” letter from the SEC to the
  effect that the proposed sale, pledge, or transfer of such Restricted Securities
  without registration will not result in a recommendation by the staff of the
  SEC that action be taken with respect thereto; or (iii) any other evidence reasonably
  satisfactory to counsel to the Company to the effect that the proposed sale,
  pledge, or transfer of the Restricted Securities may be effected without registration
  under the Securities Act, whereupon the Holder of such Restricted Securities
  shall be entitled to sell, pledge, or transfer such Restricted Securities in
  accordance with the terms of the notice given by the Holder to the Company.
  The Company will not require such a legal opinion or “no action” letter
  (x) in any transaction in compliance with SEC Rule 144 or (y) in any transaction
  in which such Holder distributes Restricted Securities to an Affiliate of such
  Holder for no consideration, provided that each transferee agrees in
  writing to be subject to the terms of this Section 2.10. Each certificate
  or instrument evidencing the Restricted Securities transferred as above provided

 10

 shall bear, except if such transfer is made pursuant to SEC Rule 144, the
  appropriate restrictive legend set forth in Section 2.10(b), except that
  such certificate shall not bear such restrictive legend if, in the opinion of
  counsel for such Holder and the Company, such legend is not required in order
  to establish compliance with any provisions of the Securities Act.

                2.11
  Termination of Registration Rights. The right of any Holder to request
  inclusion of Registrable Securities in any registration pursuant to Section
  2.1 or Section 2.2 shall terminate upon the earliest to occur of:

                     (a)
  the closing of a Deemed Liquidation Event, as such term is defined the Certificate
  of Designation with respect to the Series A Preferred Stock;

                     (b)
  when all of such Holder’s Registrable Securities could be sold without
  restriction under SEC Rule 144 within any 90-day period; or

                     (c)
  the fifth (5th) anniversary of the closing of the IPO.

           3. Information
  and Inspection Rights

                3.1
  Delivery of Financial Statements. The Company shall deliver to each Holder:

                     (a)
  as soon as practicable after the end of each fiscal year of the Company, a copy
  of the annual consolidated financial statements of the Company consisting of,
  at least, balance sheets and statements of income and cash flow for such period,
  prepared in accordance with GAAP, audited by independent certified public accountants
  of recognized standing selected by the Company;

                     (b)
  as soon as practicable after the end of each of the first three (3) quarters
  of each fiscal year of the Company, a copy of the quarterly unaudited consolidated
  financial statements of the Company consisting of, at least, balance sheets
  and statements of income and cash flow for such period, prepared in accordance
  with GAAP (except that such financial statements may (i) be subject to normal
  year end audit adjustments and (ii) not contain all notes thereto that may be
  required in accordance with GAAP); and

                     (c)
  with respect to the financial statements called for in Section 3.1(a) and
  Section 3.1(b), an instrument executed by the chief financial officer
  and chief executive officer of the Company certifying that such financial statements
  were prepared in accordance with GAAP consistently applied with prior practice
  for earlier periods (except as otherwise set forth in Section 3.1(b) and
  fairly present the financial condition of the Company and its results of operation
  for the periods specified therein.

 If, for any period, the Company has any subsidiary whose accounts are consolidated
  with those of the Company, then in respect of such period the financial statements
  delivered pursuant to the foregoing sections shall be the consolidated and consolidating
  financial statements of the Company and all such consolidated subsidiaries,
  provided that the audit referred to in Section 3.1(b) shall not
  be required to include and cover any consolidating financial statements.

 11

 Notwithstanding anything in this Section 3.1 to the contrary, the Company
  may cease providing the information set forth in this Section 3.1 during
  the period starting with the date sixty (60) days before the Company’s
  good faith estimate of the date of filing of a registration statement if it
  reasonably concludes it must do so to comply with the SEC rules applicable to
  such registration statement and related offering; provided that the Company’s
  covenants under this Section 3.1 shall be reinstated at such time as
  the Company is no longer actively employing its commercially reasonable efforts
  to cause such registration statement to become effective.

                3.2
  Inspection Rights. The Company shall permit each Major Investor, at such
  Major Investor’s expense, for any proper purpose, to visit and inspect
  the Company’s properties; examine its books of account and records; and
  discuss the Company’s affairs, finances, and accounts with its officers,
  during normal business hours of the Company as may be requested with reasonably
  advance notice by the Major Investor; provided, however, that the Company
  shall not be obligated pursuant to this Section 3.2 to provide access
  to any information that it reasonably and in good faith considers to be a trade
  secret or confidential information (unless covered by an enforceable confidentiality
  agreement, in form and substance acceptable to the Company) or the disclosure
  of which would adversely affect the attorney-client privilege between the Company
  and its counsel.

                3.3
  Termination of Information and Inspection Rights. The covenants set forth
  in Section 3.1 and Section 3.2 shall terminate and be of no further
  force or effect (i) immediately before the consummation of the IPO; (ii) when
  the Company first becomes subject to the periodic reporting requirements of
  Section 12(b), 12(g) or 15(d) of the Exchange Act or (iii) upon a Deemed Liquidation
  Event; or (iv) upon the agreement of holders of more than 66 2/3% of the Series
  A Preferred Stock, whichever event occurs first.

                3.4
  Confidentiality. Each Investor agrees that such Investor will keep confidential
  and will not disclose, divulge, or use for any purpose (other than to monitor
  its investment in the Company) any confidential information obtained from the
  Company pursuant to the terms of this Agreement (including notice of the Company’s
  intention to file a registration statement), unless such confidential information
  (a) is known or becomes known to the public in general (other than as a result
  of a breach of this Section 3.4 by such Investor), (b) is or has been
  independently developed or conceived by the Investor without use of the Company’s
  confidential information, or (c) is or has been made known or disclosed to the
  Investor by a third party without a breach of any obligation of confidentiality
  such third party may have to the Company; provided, however, that an
  Investor may disclose confidential information (i) to its attorneys, accountants,
  consultants, and other professionals to the extent necessary to obtain their
  services in connection with monitoring its investment in the Company; (ii) to
  any prospective purchaser of any Registrable Securities from such Investor,
  if such prospective purchaser agrees to be bound by the provisions of this Section
  3.4; (iii) to any Affiliate, partner, member, stockholder, or wholly owned
  subsidiary of such Investor in the ordinary course of business, provided
  that such Investor informs such Person that such information is confidential
  and directs such Person to maintain the confidentiality of such information;
  or (iv) as may otherwise be required by law, provided that the Investor
  promptly notifies the Company of such disclosure and takes reasonable steps
  to minimize the extent of any such required disclosure.

 12

           4. Miscellaneous.

                4.1
  Successors and Assigns. Except as otherwise provided herein, the terms
  and conditions of this Agreement shall inur to the benefit and be binding upon
  the respective successors and assigns of the parties (including permitted transferees
  of any shares of Registrable Securities); provided, however, that, with
  respect to any permitted transfer by a Holder, (i) the Company is, within a
  reasonable time after such transfer, furnished with written notice of the name
  and address of such transferee and the Registrable Securities with respect to
  which such rights are being transferred; and (ii) such transferee agrees in
  a written instrument delivered to the Company to be bound by and subject to
  the terms and conditions of this Agreement, including the provisions of Section
  2.10. Nothing in this Agreement, express or implied, is intended to confer
  upon any party other than the parties hereto or their respective successors
  and permitted assignees any rights, remedies, obligations or liabilities under
  or by reason of this Agreement, except as expressly provided herein. The Agent,
  the Lenders (as defined in Exhibit A hereto) and other holders of Senior
  Liabilities (as defined in Exhibit A hereto, including replacement agents
  and lenders) are express intended third party beneficiaries of this Agreement,
  including Exhibit A. Any purported transfer of any shares of Registrable
  Securities in violation or noncompliance with this Section 4.1 shall
  be null and void.

                4.2
  Governing Law. This Agreement shall be governed by, and construed in
  accordance with, the laws of the State of Delaware, regardless of the laws that
  might otherwise govern under applicable principles of conflicts of law.

                4.3
  Counterparts; Facsimile. This Agreement may be executed in two or more
  counterparts, each of which shall be deemed an original, but all of which together
  shall constitute one and the same instrument. This Agreement may also be executed
  and delivered by facsimile signature and in two or more counterparts, each of
  which shall be deemed an original, but all of which together shall constitute
  one and the same instrument.

                4.4
  Titles and Subtitles. The titles and subtitles used in this Agreement
  are for convenience only and are not to be considered in construing or interpreting
  this Agreement.

                4.5
  Notices. All notices and other communications given or made pursuant
  to this Agreement shall be in writing and shall be deemed effectively given
  upon the earlier of actual receipt or: (i) personal delivery to the party to
  be notified; (ii) when sent, if sent by electronic mail or facsimile during
  the recipient’s normal business hours, and if not sent during normal business
  hours, then on the recipient’s next business day; (iii) five (5) days after
  having been sent by registered or certified mail, return receipt requested,
  postage prepaid; or (iv) one (1) business day after the business day of deposit
  with a nationally recognized overnight courier, freight prepaid, specifying
  next-day delivery, with written verification of receipt. All communications
  shall be sent to the respective parties at their addresses as set forth on Schedule
  A hereto, or to the principal office of the Company as set forth below and
  to the attention of the Chief Executive Officer, in the case of the Company,
  or to such email address, facsimile number, or address as subsequently modified
  by written notice given in accordance with this Section 4.5.

 13

                If
  to the Company, at:

  

                 ExamWorks,
  Inc.

                 3280
  Peachtree Road NE

                 Suite
  2625

                 Atlanta,
  GA 30305

                 Attn:
  Richard E. Perlman, Co-Chairman

                 Facsimile
  No.: (646) 358-1779

                 Email:
  richardperlman@examworks.com

  

                 with
  a copy to:

  

                 Paul,
  Hastings, Janofsky & Walker LLP

                 600
  Peachtree Street, N.E.

                 Suite
  2400

                 Atlanta,
  GA 30308

                 Attention:
  Reinaldo Pascual

                 Facsimile
  No.: (404) 685-5227

                 Email:
  reypascual@paulhastings.com

                4.6
  Amendments and Waiver. Any term of this Agreement may be amended and
  the observance of any term of this Agreement may be waived (either generally
  or in a particular instance, and either retroactively or prospectively) only
  with the written consent of the Company and the holders of a majority of the
  Registrable Securities then outstanding; provided that the Company may
  in its sole discretion waive compliance with Section 2.10(c) (and the
  Company’s failure to object promptly in writing after notification of a
  proposed assignment allegedly in violation of Section 2.10(c) shall be
  deemed to be a waiver); and provided further that any provision hereof
  may be waived by any waiving party on such party’s own behalf, without
  the consent of any other party. Notwithstanding the foregoing, this Agreement
  may not be amended or terminated and the observance of any term hereof may not
  be waived with respect to any Investor without the written consent of such Investor,
  unless such amendment, termination, or waiver applies to all Investors in the
  same fashion. The Company shall give prompt notice of any amendment or termination
  hereof or waiver hereunder to any party hereto that did not consent in writing
  to such amendment, termination, or waiver. Any amendment, termination, or waiver
  effected in accordance with this Section 4.6 shall be binding on all
  parties hereto, regardless of whether any such party has consented thereto.
  No waivers of or exceptions to any term, condition, or provision of this Agreement,
  in any one or more instances, shall be deemed to be or construed as a further
  or continuing waiver of any such term, condition, or provision. Notwithstanding
  the foregoing in this Section 4.6, no amendment or modification of either
  Section 2.1(a) (or any other term, provision or section herein, if any,
  relating to the payment of any Liquidated Damages) or Section 2.1(d) (including
  Exhibit A hereto) shall be permitted or legally valid without the prior
  written consent of the Agent.

                4.7
  Severability. In case any one or more of the provisions contained in
  this Agreement is for any reason held to be invalid, illegal or unenforceable
  in any respect, such invalidity, illegality, or unenforceability shall not affect
  any other provision of this Agreement, and such invalid, illegal, or unenforceable
  provision shall be reformed and construed so that it will be valid, legal, and
  enforceable to the maximum extent permitted by law.

 14

                4.8
  Aggregation of Stock. All shares of Registrable Securities held or acquired
  by Affiliates shall be aggregated together for the purpose of determining the
  availability of any rights under this Agreement and such Affiliated persons
  may apportion such rights as among themselves in any manner they deem appropriate.

                4.9
  Additional Investors. Notwithstanding anything to the contrary contained
  herein, if the Company issues additional shares of the Company’s Series
  A Preferred Stock after the date hereof, whether pursuant to the Subscription
  Agreement or otherwise, any purchaser of such shares of Series A Preferred Stock
  may become a party to this Agreement by executing and delivering an additional
  counterpart signature page to this Agreement, and thereafter shall be deemed
  an “Investor” for all purposes hereunder. No action or consent by
  the Investors shall be required for such joinder to this Agreement by such additional
  Investor, so long as such additional Investor has agreed in writing to be bound
  by all of the obligations as an “Investor” hereunder.

                4.10
  Entire Agreement. This Agreement (including any Schedules hereto) and
  the other documents delivered pursuant hereto, constitute the full and entire
  understanding and agreement among the parties with respect to the subject matter
  hereof, provided that, the parties hereto acknowledge and agree that
  (i) the Series A Preferred Stock is subject to the terms and conditions of the
  Certificate of Designation with respect thereto and (ii) the parties hereto
  are subject to the terms and conditions of that certain Stockholders Agreement
  by and among ExamWorks Holdings, LLLP, the other stockholders party thereto
  and the Company, dated as of July 14, 2008, as amended.

                4.11
  Dispute Resolution. The parties (a) hereby irrevocably and unconditionally
  submit to the jurisdiction of the federal and state courts located within the
  geographic boundaries of the United States District Court for the District of
  New Castle County, Delaware for the purpose of any suit, action or other proceeding
  arising out of or based upon this Agreement, (b) agree not to commence any suit,
  action or other proceeding arising out of or based upon this Agreement except
  in the federal and state courts located within the geographic boundaries of
  the United States District Court for the District of New Castle County, Delaware,
  and (c) hereby waive, and agree not to assert, by way of motion, as a defense,
  or otherwise, in any such suit, action or proceeding, any claim that it is not
  subject personally to the jurisdiction of the above-named courts, that its property
  is exempt or immune from attachment or execution, that the suit, action or proceeding
  is brought in an inconvenient forum, that the venue of the suit, action or proceeding
  is improper or that this Agreement or the subject matter hereof may not be enforced
  in or by such court. Each of the parties to this Agreement consents to personal
  jurisdiction for any equitable action sought in the U.S. District Court for
  the District of New Castle County, Delaware or any court of the State of Delaware.

                4.12
  Delays or Omissions. No delay or omission to exercise any right, power,
  or remedy accruing to any party under this Agreement, upon any breach or default
  of any other party under this Agreement, shall impair any such right, power,
  or remedy of such nonbreaching or nondefaulting party, nor shall it be construed
  to be a waiver of or acquiescence to any such breach or default, or to any similar
  breach or default thereafter occurring, nor shall any waiver of any single breach
  or default be deemed a waiver of any other breach or default theretofore or
  thereafter occurring. All remedies, whether under this Agreement or by law or
  otherwise afforded to any party, shall be cumulative and not alternative.

 15

      IN WITNESS WHEREOF, the parties have executed
  this Agreement as of the date first written above.

			
	  	   	EXAMWORKS, INC.
	  
	  
	  
	 By:	 	  
	 	 	

	 Name:	   	 J. Miguel Fernandez de Castro
	 Title:	 	 Chief Financial Officer

 [Investor Rights Agreement Signature Page]

			
	  	 	 INVESTOR:

      
 
	 
	  
	  
	 By:	   	
 
 
	 Name:	 	
 
 
	 Title:	 	
 
 
	  
	 Address:	 	
 
 
	  	 	
 

	  
	 Phone Number:	 	
 
 
	 Fax Number:	 	
 
 
	 Email:	 	
 
 

 [Investor Rights Agreement Signature Page]

 SCHEDULE A

  

  Investors

 Investor Name

  Address

  Phone Number

  Fax Number

  Email

  

  Investor Name

  Address

  Phone Number

  Fax Number

  Email

 Investor Name

  Address

  Phone Number

  Fax Number

  Email

 [Schedule A to Investor Rights Agreement]

 Exhibit A to Investor Rights Agreement

      For good and valuable consideration, the receipt,
  adequacy and sufficiency of which are hereby acknowledged, each signatory to
  the Investor Rights Agreement (intending to be legally bound) hereby unconditionally
  and irrevocably agrees as follows; capitalized terms used below are defined
  in Section 15 hereof):

        1. Each Investor and Company agrees that the
    payment of any and all Junior Liabilities shall be and hereby is expressly
    made subordinate and junior in right of all Senior Liabilities being Satisfied,
    and all of the Senior Liabilities shall be Satisfied (including, without limitation,
    all interest accruing on any Senior Liabilities after commencement of any
    Proceeding whether or not such interest is allowable in any such Proceeding)
    before Investor shall be paid anything (of any kind or character, other than
    the accrual of dividends) on account of any of the Junior Liabilities; and
    until all of the Senior Liabilities are Satisfied, Company shall not at any
    time make, and Investor shall not demand, receive, retain, or accept, either
    directly or indirectly, payment (of any kind or character, other than the
    accrual of dividends) of all or any part of the Junior Liabilities without
    the prior written consent of Agent; provided, however, so long
    as no Senior Default has occurred and is continuing or would result therefrom
    and Borrowers are in compliance with the financial covenants set forth in
    the Loan Agreement both immediately before and will be in compliance therewith
    after any such contemplated payment, Company will be permitted to pay, and
    Investor may receive and accept, the applicable portion of the Junior Liabilities
    in cash; provided, further, if any Senior Default then exists
    or would be created or result, no such payment of any Junior Liabilities will
    be permitted.

        2. Company shall provide Investor with prompt
    (and in any event, within ten (10) days of the occurrence of any Senior Default)
    notice, provided that Agent may, in its sole discretion and without any obligation
    to do so, provide notice of such Senior Default directly to Investor. If Investor
    receives any payment from Company in respect of any of the Junior Liabilities
    in contravention of this Exhibit agreement (this “Exhibit”),
    such payment shall not be commingled with any assets of Investor, but shall
    be received and held in trust for Agent and Lenders and promptly turned over
    and delivered by Investor to Agent.

        3. (a) In the event of any Proceeding, the
    Senior Liabilities shall first be paid in full before Investor shall be entitled
    to receive and to retain any payment or distribution in respect of the Junior
    Liabilities. Agent may, at its sole discretion (and for the benefit of Lenders
    and Agent), in the name of Investor or otherwise, demand, sue for, collect,
    receive and receipt for any and all such payments or distributions, and file,
    prove, and vote or consent in any such proceedings identified in this Section
    3(a) with respect to, any and all claims of Investor relating to the Junior
    Liabilities.

      (b) Until the Senior Liabilities are Satisfied
  and notwithstanding anything contained in any other instrument, agreement or
  document to the contrary, Investor shall not take any Subordinated Collection
  Action unless payment of the Junior Liabilities is otherwise expressly permitted
  by the terms of Section 1 hereof.

 Last updated on May 2006

 1

        4. Investor shall not without the prior written
    consent of Agent: (a) sue for, demand, transfer or assign, or attempt to enforce
    or collect, any Junior Liabilities or any rights in respect thereof; (b) request,
    accept or take any lien, assignment, pledge, or security interest in any asset
    or property of Company as security for any Junior Liabilities; or (c) commence,
    or join with any other creditor in commencing, any Proceeding, unless in each
    case payment of the Junior Liabilities is otherwise expressly permitted by
    the terms of Section 1 hereof. Investor agrees that Investor will not
    at any time (directly or indirectly) contest the validity, perfection, priority
    or enforceability of the security interest and liens in any property or assets
    of Company granted, conveyed, assigned or pledged to Agent pursuant to the
    Loan Agreement and the Financing Agreements, and hereby agrees not to hinder
    Agent or take a position adverse to Agent in the defense of any action contesting
    the validity, perfection, priority or enforceability of any such security
    interest and liens.

        5. This Exhibit shall in all respects be a
    continuing agreement and shall remain in full force and effect (notwithstanding,
    without limitation, any Proceeding) until the earlier of (a) such time as
    the Senior Liabilities have been Satisfied, and (b) the consummation of the
    Company’s IPO (as defined in the Investor Rights Agreement).

        6. Agent and Lenders may, from time to time,
    whether before or after any discontinuance of this Exhibit, at their sole
    discretion and without notice of any kind to Investor, extend or renew for
    one or more periods (whether or not longer than the original period), alter,
    amend, modify, refinance or exchange, or release or compromise, any obligation
    or liability of any nature of any obligor with respect to, in each case, any
    of the Senior Liabilities, the Loan Agreement or any Financing Agreement (including,
    without limitation, the terms and provisions relating to the principal amount
    outstanding thereunder, the rate of interest thereof, the payment terms thereof
    and the provisions thereof regarding default, or any other matter whatsoever).

        7. Agent shall not be prejudiced in any of
    its rights under this Exhibit by any act or failure to act of Company, any
    other Borrower, or Investor, or any noncompliance of Company, any other Borrower
    or Investor with any agreement or obligation, regardless of any knowledge
    thereof which Agent may have or with which Agent may be charged.

        8. No delay on the part of Agent in the exercise
    of any right or remedy shall operate as a waiver thereof, and no single or
    partial exercise by Agent of any right or remedy shall preclude other or further
    exercise thereof or the exercise of any other right or remedy; nor shall any
    modification, amendment or waiver of any of the terms or provisions of this
    Exhibit be binding upon Agent except as expressly set forth in a writing duly
    signed and delivered by Agent. Investor acknowledges that Investor has had
    the opportunity to obtain independent legal advice in connection with the
    terms and provisions of this Exhibit.

        9. Investor acknowledges and agrees that the
    provisions of this Exhibit shall be binding on Investor in favor of any holder
    of the Senior Liabilities, including without limitation any replacement agent
    or lender. The provisions of this Exhibit shall be reinstated if at any time
    any payment of any of the Senior Liabilities is rescinded or must

 [Schedule A to Investor Rights Agreement]

   otherwise be returned by the holders of the Senior Liabilities for any reason
    whatsoever (including, without limitation, any Proceeding) all as though such
    payment had not been made.

        10. Investor shall promptly execute and deliver
    such further documents or certificates and take such further reasonable action
    as Agent may from time to time reasonably request to more fully carry out
    the intent and purpose of this Exhibit.

        11. Notices to be provided to Agent pursuant
    to this Exhibit shall be as follows: 222 South Riverside Plaza, 30th
    Floor, Chicago, Illinois 60606; Attention: Phil Renwick, Vice President;
    Telephone No. (312) 704-7349; Facsimile No. (312) 704-4127; with a copy to:
    Duane Morris LLP, 190 South LaSalle Street, Suite 3700, Chicago, Illinois
    60603; Attention: Brian P. Kerwin, Esq.; Telephone No. (312) 499-6737; Facsimile
    No. (312) 499-6701.

        12. Investor hereby assumes responsibility
    for keeping informed of the financial condition of Company and of all other
    circumstances bearing upon the risk of nonpayment of the Senior Liabilities
    and Junior Liabilities, and agrees that Agent has no duty to advise Investor
    of information known to Agent regarding such condition or any such circumstances.

        13. Investor and Company (a) submit for themselves,
    respectfully, in any legal action or proceeding relating to this Exhibit,
    to the non-exclusive general jurisdiction of the courts of the State of Illinois,
    the courts of the United States of America for the Northern District of Illinois
    and Appellate Courts from any thereof; and (b) waive to the fullest extent
    permitted by law in connection with any such action or proceeding any objection
    that they may now or hereafter have to the venue of any such action or proceeding
    in any such court or that such action or proceeding was brought in an inconvenient
    court and agree not to plead or claim the same.

        14. INVESTOR, COMPANY AND AGENT WAIVE (TO
    THE FULLEST EXTENT PERMITTED BY LAW) ANY RIGHT TO A TRIAL BY JURY IN ANY ACTION
    OR PROCEEDING (INCLUDING, WITHOUT LIMITATION, ANY COUNTERCLAIM) ARISING OUT
    OF THIS EXHIBIT.

        15. As used herein, the following capitalized
    terms have the following meanings:

      “Agent” means Fifth Third Bank,
  an Ohio banking corporation, together with its successors and assigns, in its
  capacity as administrative agent for Lenders.

      “Borrowers” means, collectively,
  Company, Southwest Medical Examination Services, Inc., The Ricwel Corporation,
  CFO Medical Services, LLC, Diagnostic Imaging Institute, Inc., Ricwel of West
  Virginia, LLC, Pacific Billing Services, Inc., Set-Aside Solutions, LLC, Marquis
  Medical Administrators, Inc., IME Software Solutions, LLC, Florida Medical Specialties,
  Inc., ExamWorks Medical of New York, LLC, and the subsidiaries of Company that
  may from time to time hereafter become parties to the Loan Agreement.

 [Schedule A to Investor Rights Agreement]

      “Company” means ExamWorks,
  Inc., a Delaware corporation.

      “Investor” means each of the
  investors listed on Schedule A to the Investors Rights Agreement, as such Schedule
  is supplemented or modified form time to time, including, without limitation,
  each holder of Registrable Securities (as defined in the Investors Rights Agreement)
  and the transferees thereof.

      “Junior Liabilities” means
  any and all liability or obligation of Company to make any penalty or liquidated
  damages payment (or payment of any other kind) to Investor under and pursuant
  to Section 2.1 of the Investor Rights Agreement.

      “Lenders” means, collectively,
  (a) Fifth Third Bank, an Ohio banking corporation in its individual capacity,
  (b) Bank of America, N.A., and (c) any and all other financial institutions,
  banks and lenders that may at any time from time to time be a party to the Loan
  Agreement.

      “Loan Agreement” means the
  Loan and Security Agreement dated as of December 18, 2009, as amended pursuant
  to certain consents and amendments among Agent, Lenders, Company and other Borrowers,
  as the same may be further amended, supplemented or modified from time to time.

      “Person” means any person or
  entity of any kind.

      “Proceeding” means any insolvency,
  bankruptcy, receivership, custodianship, liquidation, reorganization, readjustment,
  assignment for the benefit of creditors, marshaling of assets or liabilities,
  or other proceeding for the liquidation, dissolution or other winding up, of
  Company or its assets or property (including, without limitation, any such proceeding
  under the U.S. Bankruptcy Code), or otherwise, whether voluntary or involuntary.

      “Satisfied” means, with respect
  to the Senior Liabilities, that all of the Senior Liabilities shall have been
  indefeasibly paid in full in cash, and all financing arrangements and accommodations
  by and among the Borrowers, Agent and Lenders shall have been terminated and
  Lenders have no obligation to make any loans, financial accommodations or advance
  any funds that would constitute Senior Liabilities to any Borrower, and the
  cancellation of all related letters of credit, bankers’ acceptances, bank
  products, swaps and other hedging products or similar instruments issued under,
  or otherwise secured by or collateralized through, the Loan Agreement or any
  of the Financing Agreements.

      “Senior Default” means the
  occurrence or existence of any “Default” or “Event of Default”
  (each as defined in the Loan Agreement).

      “Senior Liabilities” means,
  collectively, any and all liabilities, obligations and indebtedness of each
  Borrower (whether for principal, interest, fees, charges, indemnities, fees,
  costs, expenses, prepayment fees, default interest, reasonable attorneys’
  fees and any other sums or amounts) howsoever created, arising or evidenced,
  whether direct or indirect, absolute or contingent, now or hereafter existing
  or arising, or due or to become due, to Agent and Lenders (or any replacement
  agent or lender in connection any refinancing of any or all of the Senior Liabilities),
  including, without limitation, under and pursuant to the Loan Agreement or the
  Financing Agreements (as defined in the Loan Agreement); it being expressly
  understood and

 [Schedule A to Investor Rights Agreement]

 agreed that the term “Senior Liabilities”, as used herein, shall
  include, without limitation, any and all interest accruing on any of the Senior
  Liabilities after the commencement of any Proceeding, notwithstanding any provision
  or rule of law or statute which might restrict the rights of Agent and Lenders,
  as against Company or any other Borrower or any other Person, to collect such
  interest, and any costs of collection or enforcement (including reasonable attorneys’
  fees).

 “Subordinated Collection Action” means (x) any demand of
  or for or acceleration of any or all of the Junior Liabilities, (y) the filing
  or initiating, or joining with any Person in filing or initiating, a Proceeding
  against, Company, or (z) any judicial proceeding or other action of any kind
  initiated or taken by Investor, or by Investor in concert with any other Person
  or by any other Person with the support of Investor, against Company or any
  other Person to collect the Junior Liabilities.

 [Schedule A to Investor Rights Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00178-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00178-of-00352.parquet"}]]